International Pharmaceutical Abstracts 1997: Vol 34 Index

647 Pages·1997·268.4 MB·English

Index to Volume Thirty-Four
INTERNATIONAL PHARMACEUTICAL ABSTRACTS
January 15, 1997 — June 30, 1997
3400001 — 3400764 15 Mar 3402—8 36403145 7 15 May 3405438 — 3405822
3400765 — 3401481 30 Mar 3403—4 35404811 8 30 May 3405823 — 3406422
3401482 — 3402194 15 Apr 3404—1 31409484 2 15 Jun 3406423 — 3407084
3492195 — 3402860 30 Apr 3404—8 34405343 7 30 Jun CUMULATIVE INDEX
SUBJECT INDEX
Numbers buserelin; buccal, 3405037, 3406559 insulin; dosage forms, 3402349; liposomes,
caffeine; transdermal, 3405993 3403654; metabolism, 3401318; nasal, 3400897;
calcitonin eel; pulmonary, 3400898 pulmonary, 3400898
2B1; neoplasms; dosage, 3403577 calcitonin human; colon, 3401920 isomaltose; intestinal, 3406218
6366-A; radioimmunoassay; metabolites, 3402559 calcitonin human derivatives; fatty acids, 3406241 isoniazid; AIDS, 3400472
calcitonin salmon; nasal, 3405046 ketoprofen; hydrogels, 3400318
calcitriol; osteoporosis, 3401646 R-ketoprofen; enterohepatic circulation, 3403270
calcium; overview, 3403100 S-ketoprofen; enterohepatic circulation, 3403270
calcium polycarbophil; swelling, 3406587 ketorolac tromethamine; availability, 3400225
Cam-2445; availability, 3403662 L-693989; pulmonary, 3405047
capsaicin; percutaneous, 3403016; skin, 3401690, levodopa; interactions, 3401843
3403674 levofloxacin; dosage forms, 3406875
captopril; percutaneous, 3403648; rat intestine, lidocaine; skin, 3403667; transdermal, 3405993
3403647
A-64077, see Zileuton carbamazepine; interactions, 3400887 li3d4o0ca3i6n6e7 hydrochloride; dosage, 3400828; skin,
AA--6747606023,; spehea rEmnaaclokkiinreetni cs; methodology, 3404702 ccehfetniobduitoeln,; 3m4id0d1l9e1 3 ear fluid, 3401908 macromolecules; lungs, 3401917
AAAA-bbAPia38bbpnCh46rrpv0Pa7leee4r,i1svv1c9tm ii3ai.aaat9g1stctia e,ioeyte on di nso sA snem;ean e le;rwA pi BrceaTdasb-rcbn7rur i1egp9v Ati siaasoptnopescld;ii actanuitenoiwanoc ncsdeo,prf tu agsCb eolele l,De rgeusg s,o f ccccccilhoyr33pallco44rrolom0o0ironof03tosyllh46qp oyru87oxnosir31am tni; cyien ismc;enuio ;o;lndr aa;rilte iui,cinm ntntr;taege3le r v4 raia0ocfaecr0tavwat2ica,litoi3, oonl 0nrsa3s;;3b,,4 i 4 l00pip3633hte46y40aa04,r0r11 9lm586 a9 38ce740oq70;ku 3 ii0vnn1aea9ltne ioncccsay,p, s ules, mmmmm(mma—eeeeaaz)tcctgga-fllhnnpomoooeeerefdfssrmneoeiititlnnuuinhoaan,mmogmme l yia ;;ct3do es4xiu ig0rncadla1ctuceys9 iim;co1dn iesd;1ankri tc iaiuenotccm;,emoa ;;pml a3 pdr4aoccid0rsooseai5mmcogs9pponeo8aan,sn8rrv ,sii o ,ss3l oo4u3nn0t43ssi504,,o930 n225,29339 6449 004353 4920996469 07
Abciximab 3404228; pulmonary, 3405047; triglyceride methyl salicylate; skin, 3400241
angioplasty, 3406755 vehicles, 3403269 metoclopramide; intranasal, 3404991
coronary disease; role, 3401054 1-(2-deoxy-2-fluoro-B-L-arabinofuranosyl)-5- metoprolol; interactions, 3401681
pharmacodynamics; overview, 3404387 methyluracil, 3405326 metoprolol tartrate; percutaneous, 3402336
therapy; overview, 3401159 desmopressin acetate; comparisons, 3403285 MFB-1041; solid dispersions, 3403664
AAAAbbbbuentedlioloclrmmiemztoiaa,sntl icaiohlsnte;u ie s ep esAav imamnlpo;uhsa octtthihoeaenrtr,uia pscy;3i, 4n 0 p35e4B5r04 f62u7 m3e1s , 3406887 ddddeeei3txxci4ttlrrr0oeaaf6lnnie2;sxn1 ;;a8 cb puiucnstcloeamdsloti,niu namar3;ly4, ,0 2m35o43i80s446t0,u25 r10e834, 47 0 53043072;4 42i;n tetsetirnpaeln,e s, mmmmmiiioibrcddetoeafalnzrzsaoaa;zdlp oiaillmnpe;;eh ;; a rpnmhiraanaestcrvaeomlir,kaea iwcc,not3 eki4oti03nin6s4ce,00st 86,i16 c3 4s43,804 60563434610 53;2 80r at intestine
databases; congenital, 3402183 3401688 validity, 3400582; skin, ions, 3406902
folic acid; womens knowledge, 3402974 didanosine; comparisons, 3403020; vehicles, moisture; granules, 3402875
Abortifacients 400247 molsidomine, 3401912
Campyloneurum major; folk medicine, 3400540 digoxin; interactions, 3403007 morphine sulfate; rectal, 3404631; SL, 3405040
medicinal plants; Vanuatu, 3403916 dihydroergotamine; percutaneous, 3402353 morphine-6-glucuronide; intranasal, 3405031
methotrexate; combined therapy, 3401106; ectopic dihydroergotamine mesylate; intranasal, 3405989 N-696; rabbit eyes, 3405240
pregnancy, 3400397 1,3-dinitrobenzene; rat intestine, 3406213 nanoparticles; copolymers, 3406015
mifepristone; overview, 3405676; pharmacists dirithromycin; review, 3401755 naringin; citrus products, 3401314
attitudes, 3405360 DMP-728; absorption enhancers, 3403025; new drugs; interactions, 3401676
misoprostol; combined therapy, 3401106 intestines, 3403281 nicomorphine hydrochloride; intramuscular,
npPhreyeolgplnliaatinsscm ys;,b r aso3iv4le0ire1vn1is8ies4w; , f3ol4k0 3m4e0d3i cine, 3400540 ddor3ux4go0sr3;u 1b3ia4cb;is nor bpithoiyaodvnra oicleahnblhiolarinitcdyee,r; s ,3 4li03p04o20s45o80m;3e 8s,;f oo3adg4 i0n5g9,8 6 nnii3cf4oetd0ii0np2ei6 n9ep; o laScLr,i le3x4;0 29he7a1t effects, 3403860
AbracahpmmHimoisnoeibiheucprntpfusatnii4ttiaeporhngr0r iprprpmoiaa6hriooratnArcifn0ooc;rn;yese ssi7e ;ptntpsx4cct o;mohta aion ilostldvecm;l;ecerie; bi ;siun, p i,ud gcain mou tocde3;vctm otodi 4eeerbmtdr 0arsucib,v6ladyon iit;t1en hmeenos23dew,gbdec6rr4 e,i do aon0 nm 3pim2tpey4c3eh9la,di0e4;8 it 5r0 8ya3a35, ntp6a4 6chy0 n07ee,t3;5r 6,i 4a9 c30p4oey41332at,034h4g i180u0c1l8311sa0 416,n 6003t5 633s9 ,44 022 051 eeeeeebspnrnmpiim33ptaayionneea4er4sltntxtrtat0t0kmheeeadccihi2sr3bprpihuntroo36ahroaeeitepcd8r7lansr;anotoi;32a,n i;nii nll,; enoee,eoo n aots 3;vgosiuu, 4re3t,ys3nst a rr04,;o4,olnva6 0 d0 r a33in55is1a44seml3a5u31d3d00wuil4m7i457e,,56pc0;o 050 r 99oo1 g3;m s70s3r36 a3o58apa544l4m;;,ep6,03ke0 rh; i,5s1cy d 0,gs36u,3n e5tt42 o43err0ar000iy43aa n33a 60t4let40,0u40rof02 m12i0ua21 c363is26 sl;24,5c,7u ;0 5ro85 e r;t,333n r p442eau0043nun3l,3a4sm5m s60d,a4o45e l39n2r7,4;am5 0 ar06ly;2 40; n3noooonppicule-poax3rsttpirnhnyie44rytgaitinbvi0l0iob;thviet 1d n3eiraaene6un6omwolmrzs9cns,5aebmi;ol;0;t 6teid ne, n hceoe3 sidz ;oct;k4ioe oxii3e 0npnnsdty4t1r,,paemcpo0 e3esmeeipp31r;it33hrna62 cino4c4rn7u ceru0a0aat4 e;tt43ema s ai4r8anifono68etsonres68,aoresoo;t um ;;lu us ss 3il,,,sn4a r putte0eer3iv30sgr3io449tec4en0i0r1u0wsn1y34t,e,2,90;a, 21 1n 763e63393;on4;444 a u 000s0s6a51p,6s2l16ek 2,4i59r 15nc7433, 3u 4 4t0a02n62e27o39u4 s;,
tetanus toxoids; spontaneous, 3405902 2-ethylhexyl salicylate; percutaneous, 3402279 perfumes; skin, 3406903
Abruptio placentae; heparin; therapy failure, fentiazac; mouse skin, 3402365 phenacetin; methodology, 3401356
3405951 ferritransferrin; comparisons, 3405018 phenolsulfonphthalein; intestinal, 3404626
Absrauposn incsa;n tosntriuecntsuires, 3403908, 3403909 feirnrtoeursa ctgilouncso,n at3e4;0 36c3o8m parisons, 3405018; pphhleonryitzoiin;n isnotdeistuimn;a l, in3t4er0a6c2t1io8n s, 3403633
Abscess fluocinolone acetonide; percutaneous, 3405719 phosphorothioate oligonucleotides; percutaneous,
dgeaxltlriaunms ; cirtraadtieo laGbae li6n7g;, co3m4p0a6r8i8s3o ns, 3406883 fflluuoorreesscceeiinn iissootthhiiooccyyaannaattee; dbeixlter asnasl;t s, bi3l4e 00sa2l4ts3, pi3m4i0lp2r4o1s4t ; skin, 3406225
Absorption 3400243 piribedil; percutaneous, 3405054
acetaminophen; sustained-action tablets, 3404225 fluorouracil; enhancers, 3404261; skin, 3400266 piroxicam; cardamom oil, 3405997; orthogonal
albuterol sulfate; iontophoresis, 3406564 folic acid, 3404317 polynomials, 3401986; percutaneous, 3400494,
alcohols, methyl; inhalation, gonadorelin; iontophoresis, 3400244; lipidic 3403014; topical, 3401729
amlodipine; transdermal, 3402384 conjugates, 3405033; nanoparticles, 3402334 podofilox; topical preparations, 3406259
aromatherapy; efficacy research, 3406310 halofantrine; lymphatic transport, 3400254 polymyxin B; pulmonary, 3405047
artemisinin; Caco-2 cell permeability, 3403273 halofantrine hydrochloride; interactions, 3402329 procaine hydrochloride; phonophoresis, 3401693
artesunate; enhancers, 3404268 hesperidin; citrus products, 3401314 prodrugs; review, 3406239
ascorbic acid; silicon dioxide colloidal, 3400324 HMG-CoA reductase inhibitors; review, 3405229 progesterone; vaginal suppositories, 3406555
atosiban; comparisons, 3403285 ibuprofen; arginine, 3403187; equivalency, protirelin; iontophoresis, 3403023; lipidic
azithromycin; review, 3406649 3400257; microspheres, 3400834; transdermal, conjugates, 3405033
benzoyl peroxide; skin, 3402385 3402358 psoralens; occlusion, 3402588
berberine sulfate; liposomes, 340027! indomethacin; absorption, 3402337; nanocapsules, pyrimethamine; HIV infections, 3401910
BMS- 188667; SC, 3403288 3402343; transdermal patches, 3400270 quinolones; interactions, 3402926
International Pharmaceutical Abstracts
Absorption Subject Index
remoxipride; methodology, 3402359 ferrous fumarate; tablets, 3402423 Acamprosate; alcoholism, 3400200
ribavirin; transdermal, 3401709 fluorescein isothiocyanate dextrans; Acarbose
rifabutin, 3400482; interactions, 3401668; review, intrapulmonary transfer, 3400249 diabetes mellitus, 3404382; non-insulin-dependent,
3406649 fluvastatin; transdermal, 3405993 3406662, 3406765; overview, 3403133; review,
rifampin; tuberculosis, 3403857 gels; piroxicam, 3401729 3
rizatriptan benzoate, 3400493 1-geranylazacycloheptan-2-one; metabolism, insulin resistance; overview, 3403758
RU-58841; percutaneous, 3405053 3406226 new drugs; overview, 3404423
rufinamide; variabilities, 3403286 2-hydroxypropyl-B-cyclodextrin; complexes, overview, 3401160, 3401186
S-9977; percutaneous, 3405054 3402399; estradiol, 3403672 pharmacokinetics; kidney failure, 3403261
SshCaHr-k3 9c3a0rt4i;l agep;h arnmeaocpolkaisnmest,i cs3,4 013343052 592 is3o4p0ro5p9y8l8 myristate; aminopyrine permeation, therapy; overview, 3401159
skin; mechanisms, 3400937; models, 3402581 isopropyl palmitate, combination, triethylene Accidental falls
sodium artesunate; Caco-2 cell permeability, _ glycol _monomethy! ether, 3406013 central nervous system drugs; toxicity, —
so3d4i0u3m2 73n onivamide acetate; percutaneous, oe a aminopmyarli nep er permeation,3 40364507599 88; Acdcroulga tien,t ersaecet ioZnasf;i rlnuukrassintg homes, 3400237
3403016; skin, 3401690, 3403674 comparisons, 3404261; dihydroergotamine Accounting
somatropin; nasal, 3402356; pulmonary, 3403284 penetration, 3402353; indomethacin, 3400270; corporations; pharmacists, 3402759
stavudine; in vitro, 3402587 iontophoresis, 3406901; metoprolol, 3402336; pharmacy, community; third party debt, 3404765
sulindac; dosage forms, 3400251 percutaneous enoxaparin, 3403642; percutaneous Accreditation
TA-7552; oral, 3405096 penetration enhancement, 3400943; stratum education, pharmaceutical; ACPE, 3402819
tacrine hydrochloride; interactions, 3400228 corneum, 3402339; timolol, 3400264; health benefit programs; NCQA, 3402711
tacrolimus; race, 3404189 transdermal, 3405718 home health care; commissions, 3400619;
ta3li4n0o3lo8l6;9 enantiomers, 3405249; small intestine, la3u4r0o3yl0c2h5o line chioride; DMP-728 absorption, J34C0A2H1O3,3 3400602; pediatric critical care,
(+)-talinolol; dosage, 3405249 (+)-limonene; aminopyrine permeation, 3405988; hospital pharmacy; drug information competence,
(—)-talinolol; enantiomers, 3405249 ketoprofen, 3400318; verapamil absorption, 3402162; JCAHO pearls, 3405493
tteernboixniacfaimn;e hsyudrfraoccthalnotrsi, de3;4 0p1h6a8r6m acokinetics, li3no4l0e2i3c 55a cid; iontophoresis, 3406901 hospitals; JCAHO, 3405592
menthol; ribavirin, 3401709 laws; managed care systems, 3403524
long term care facilities; JCAHO, 3400595
terfenadine; pharmacokinetics, 3403867 (—)-menthol; aminopyrine permeation, 3405988
tthheeoopphhyylllliinnee; ainnhtyedrarcotuiso;n s,— 3—405—71s6 3403022 mmeotdhelysl, B3-c4y0c2l5o8d1e xtrin; estradiol, 3403672 pphhaarrmmaacciys,t s;i nsntuirtustiinogn alh;o mJeCs,A HO3,40 53344046 933; long
tiaprofenic acid; review, monoctanoin; aminopyrine permeation, 3405988 term care, 3402000
(+)-tiaprofenic acid; review, 5406214 nasal preparations; ciliary beat, Accreditation Commission for Home Care;
(—)-tiaprofenic acid; review, 3406214 nerolidol; percutaneous enoxaparin, 3403642 history; development, 3400619
timolol; skin, 3400264 nitroglycerin; transdermal, 3404850 Ac-Di-Sol, see Croscarmellose sodium
topical preparations; transdermal, 3403238 oleic acid; antiviral skin permeation, 3403020; ACE inhibitors, see Angiotensin converting
tretinoin; liposomal gel, 3404230; liposomes, captopril absorption, 3403647; iontophoresis, enzyme inhibitors
3405999 3406901; ketoprofen, 3400263, 3400318; Acebutolol; toxicity; pulmonary, 3400588
turrsooldaimoiln,e 3s4a0l1ic9y1l3a;te ; sussktiani, ne3d4-0a0ct2i4o1n capsules, ppeerrmceuattainoeno,u s 34d0r0u2g4 7a;b sotripmtoiloonl,, 33440050025644; Acebutolol hydrochloride; microspheres; release,
3401691 palmitoylcarnitine chloride; DMP-728 absorption, 3401510
valacyclovir; review, 3406687 3403025 Acecainide
valproic acid; interactions, 3402328 n-pentyl N-acetylprolinate; hydrocortisone, metabolites; LC, 3402560
verapamil hydrochloride; percutaneous, 3402355 3405036 models; pharmacokinetics-pharmacodynamics,
vinorelbine; review, 3401304 peppermint oil; comparisons, 3404261 3403267
water; carrageenan gel sheets, 3401721; peptides; pulmonary absorption, 3400898 Acedapsone; convulsions; rats, 3405162
ethylcellulose compacts, 3403074 phospholipids; indomethacin, 3402337; structure- Acenocoumarol
YM-022; dogs, 3406018 activity relationships, 3403643 interactions; cetirizine, 3405715; clarithromycin,
zalcitabine; comparisons, 3403020; vehicles, poly(€-caprolactone); corneal, 3402341 008; pharmacokinetics, 3400221
247 polysorbate 20; transdermal, 3405718 toxicity; hemorrhage, 3402263
zidovudine, 3403275; comparisons, 3403020; polysorbate 80; fentiazac release, 3402365
vehicles, 3400247 propylene glycol; amlodipine, 3402384; Acesulfame potassium; toxicity, 3404444
zinc acexamate; GI, 3406878 iontophoresis, 3406901; timolol, 3400264 Acetal, see 1,1-Diethoxyethane
Absorption enhance: rs 2-pyrrolidone; timolol, 3400264 Ac idoglutethimide; metabolites; (R)-(+)-
acetone; transdermal, 3405993 RMI-14514; transdermal, 3405993 aminoglutethimide, 3403243
ac3y4lc0a5r0n4i6ti nes; calcitonin salmon absorption, ssaalpiocnyilnisc; acQi.d ; satproannasrdiear,m al3,4 023344095 718 Acabestoarmptiinoon;p hesnus tained-action tablets, 3404225
alcohols, butyl; skin permeation, 3400267 sodium caprate; DMP-728 absorption, 3403025; blood levels; schistosomiasis, 3406220
alcohols, ethyl; aminopyrine permeation, mechanism of action, 3405990; progesterone combination, aspirin; analysis, 3406866
3405988; iontophoresis, 3406006, 3406901; skin absorption, 3406555 combination, aspirin, caffeine; spectrometry,
permeation, 3400267 sodium glycocholate; absorption, 3400243; 1889
all-caolhkoylls-,2 -ppryorpryoll;i dosnkeisn; pesrtmreaatutmi onc,o rn3e4u0m0,2 673 402383 sosdoimuamt rogpliync,o d3e4ox0y3c2h8o4l ate; absorption, 3400243; combination, azatadine maleate, pseudoephedrine
artesunate; skin permeation, 3404268 buccal absorption, 3405037, 3406559; pigs, hydrochloride; TLC, 3406857
calcitonin human derivatives; rats, 3406241 3402584 combination, caffeine, dipyrone; absorbance ratio,
cardamom oil; piroxicam, 3403014, 3405997 sodium lauryl sulfate; amlodipine, 3402384; 3406851
L-carvone; aminopyrine permeation, 3405988 fentiazac release, 3402365; iontophoresis, combination, chlorzoxazone, diclofenac sodium;
chpihtaorsmana;c okineticisn,e -63-4g0l5u0c3u1r onide so3d4i0u6m9 01o;l eatter;a nscdaeprtomparli,l 3a4b0so5r7p1t8i on, 3403647 cocmhbrionmaattioognr,a pchoyd,e in3e4;0 6c1o6n7c omitant therapy,
cah-oclyecsltoedreyxlt risnul;f atnea;s alt,r an3s4d0e2r3ma5l6, 3405993 ssooddiiuumm ttaauurroocdheoolxaytceh; olaabtseo;r ptaibosno,r pt3i4o0n0, 24334 00243 co3m4b0i5n8a8t2i;o n,p aidni,c l3of4e0n0a1c8 6 sodium; simultaneous
B-cyclodextrin; complexes, 3402399 soybean phosphatidylcholine; percutaneous, spectrometry, 3406859
ddeicdaencoaynlocyalr-nLi-tai-nlee;c itmheinc;h ansiosmma troofp ianc tinoans,a l 3405990 st3ea4r0i3c6 4a1c id; iontophoresis, 3406901 cosmpbeicntartoimoent,ry , me3f4e0n6a1m6i9c acid; simultaneous
absorption, 3402356 terpenes; diclofenac, 3401688 combination, sulfapyridine; LC, 3406847
dimethyl! sulfoxide; transdermal, 3405718 transport; pulmonary membranes, 3406908 compaction; melt coatings, 3402224
dimethy!-B-cyclodextrin; complexes, 3402399; turpentine; comparisons, 3404261 concomitant therapy, 3400133, 3402331, 3403537,
estradiol, 3403672; insulin nasal absorption, urea; ribavirin, 3401709 3405973
3400897; somatropin, 3403284 ABT-719; synthesis; antibacterial effects, 3402957 dissolution; crystals, 3405058
dimethylformamide; fentiazac release, 3402365 Abuse; drugs, see Drug abuse dissolution rates; granule size, 3404260
N-dodecanoyl-L-amino acid methyl esters; Abutilon tatum; steroids; activity, 3400507 extrusions; water, wax, 3400037
hydrocortisone, 3405036 Acabaria undulata; polyhydroxysteroids; floor stock; hospitals, 3405487
dodecy!-N,N-dimethyl-L-alanine; incompatibilities, antineoplastic activity, 3402633 headache; kidney failure, 3403607; nitric oxide
3403734 Acacia toxicity, 3404709
drugs; colonic, 3403057; skin, 3400937, 3403686 coacervation; ketoprofen microcapsulation, interactions; ethyl alcohol, 3403623; sumatriptan,
edetic acid; mechanism of action, 3405990 3406051 1672
effects; drug absorption, 3405038 effects; ciprofloxacin tablets, 3400957 low back pain; protocols, 3404291
enzymes; percutaneous absorption, 3404262 release; caffeine, ibuprofen, 3400306 nomenclature; Great Britain, 3401478
ethoxydiglycol; percutaneous penetration tablets; sustained-action, 3400317 osteoarthritis; protocols, 3404318
enhancement, 3 Academy of Managed Care Pharmacy pain; overview, 3401074, 3404441; pediatrics,
eucalyptol; percutaneous enoxaparin, 3403642 meetings, 3401541; P & T, 3401547 3400180, 3406323
eucalyptus oil; comparisons, 3404261; Acadesine; coronary artery bypass; meta-analysis, pellets; release, 3403467
fluorouracil, 3400266 3405675 permeation; alginate gels, 3402370
1084 International Pharmaceutical Abstracts
Subject Index
poisoning; nomograms, 3405228 2-Acetyl-5-methoxyphenol, see Paeonol toxicity; surveillance, 3400744
release; ethylcellulose, 3405724; hydrophilic N-Acetylphenylalanyl-3,5-diiodotyrosine; Acosta, A.; pharmacists; military, 3406982
matrix tablets, 3400908 analysis; enzyme kinetics, 3406171 Acquired immunodeficiency syndrome
solubility; solvents, 3403041 N-Acetylprocainamide, see Acecainide alternative medicine; bibliographies, 3407078
spheres; release, 3400283 Acetylsalicylic acid, see Aspirin amphotericin B; fat emulsions, 3404226
stability; stabilizers, 3403701 Acetylsalvianolic acid A; ischemia; cerebral, analgesisics and antipyretics, pain, 3403106
sustained-action; bioavailability, 3402348 3401613 antifungals; cryptococcal meningitis, 3401247
tableting; xylitol, 3405845 2-Acetylthiomethyl-3-(4-methylbenzoyl)- antituberculars; blood levels, 3400472;
tablets; coatings, 3406583; compaction, 3400035; propionic acid; arthritis; overview, 3405919 tuberculosis, 3402748; M. tuberculosis
starch comparisons, 3400921 Achalasia; gastrointestinal drugs; respiration resistance, 3406885
temperature; polymorphonuclear leukocytes, disorders, 3400359 antivirals; clinical studies, 3400380; comparisons,
3406752 Achillea millefolium 3400174; cytomegalovirus retinitis, 3400999;
toxicity; contamination, 3401598; liver, 3404997, oils, essential; isolation, 3403307 HIV infections, 3400175, 3400366; Medicaid
3405899; overdose, 3404901 a-peroxyachifolid; TLC, 3402570 coverage, 3403381; outcome markers, 3400173;
Acetaminophen cysteine; metabolites; urine levels, Aciclovir, see Acyclovir overview, 3404306; postexposure prophylaxis,
3405899 a ,-Acid glycoprotein; nanoparticles; stability, 3406521; review, 3401773; surrogate markers,
Acetaminophen glucuronide 3400341 3400562
metabolites; blood levels, 3406220; urine levels, Acid red 87 atovaquone; P. carinii pneumonia, 3402481
3405899 ion pairs; quaternary ammonium compounds, cidofovir, cytomegalovirus retinitis, 3400872
Acetaminophen glutathione; metabolites; urine 03718 clindamycin; protein binding, 3404625
levels, 3405899 spectrometry; berberine tablets, 3400445 colony stimulating factor; toxicity, 3402924
AAccureeittnaae mmiilennvooelppshh,e enn3 40ms5ue8lr9fca9at ep turic acid; metabolites; Acafilefdnet-nabtnaaynslie;l ; pihpmahbraamrlamacanocckoeik nienteitcisc,s , 3430450253263 6 cdoasptsso; n2e3d;2r 7u gc omthbeirnaepyd, t3h4e0ra6p9y5,4 3403207; interactions,
metabolites; blood levels, 3406220; urine levels, sufentanil; pharmacokinetics, 3405236 didanosine; combined therapy, 3402310
Ace3t4a0z5o8l9a9m ide Acgirdafitcs , fi3b4r0o4b4l1a1s t growth factor; release; vascular derpuigd emiinotelroagcyt;io nso;v errvaiteiown,a l 34th0e2r0a8py0, 3405430
incompatibilities; TrophAmine, 3400330 Ac3i4d0i0f7y3i9n g agents; hydrochloric acid; dopamine, foscarnet; peritoneal dialysis, 3401904
solubilization; 2-hydroxypropyl-B-cyclodextrin, Acidity ganciclovir, cytomegalovirus infections, 3401232
3400312 ganciclovir sodium; CMV retinitis therapy,
Actxeo-3txri4iacc0yi 2t5yda4;ic 1fif ddr yascgtieouns;i a,p ar3a4cr0y6s4t9a2l line lattice distortion, Acdaminre3deut4osgfts0sohi;5re s6mt 6iirec8nls ;e, a sieln,ot cea3rla;4c 0t2biu3of9nfs1e, r s,3 40364602136;9 7 toxicity, giom3nm4au0dn0oi1tz87ra01ot7,pi ionn3 ;4 0c0hro3gr6pi4 o n1i2c0; vaKcacpionseis',s 3s4a0r1co6m0a9,
Accseouatmbcilbeciit amntaaaettn;iih ooynond;t,ri ci ldbyseeoo;pnl huzitedlitiiohsznsasoot,nl iiuoutn3im,4o 0n1;3c3 h48l0a1o3cr 0ei3dte8a, m insoopdhieunm, mrsspoeoietdrnfiotoungrmoem lniaobncig tcroaahnrpyebhd;ori nocatc tohexla,iogc erinti3tyd4,se0 ;; 0 314i3ln0a8t0ce t1ri3acc,3 t i3o4ns0,5 02364 06623 iiinnmwtsmaueuslrniftneio-rntloghin ke ers aaylpfngaydr;;ro o wsmtmsehau, lr lrf-oac3cge4tal0otlr4e 9l7|m y6aam rnpkdhe rossmo,am ,a t3r43o04p0i05n46;12 9 2H IV
Ac3Ae4nt0no5og0ne5an8 i nmsu ricata, 3402643 Achiy3dd4sr0 o6g0e4n0 ion concentration; buffer index, ilmivetegerermsaettcurrtoeil;n ; oavcseectraavbtiieee;w s,,t ox33i44c0i0t21y90,9 7403 400135, 3401595
cgrooilrgliaianndteiecetinrnio nn;Ae ;n iAn.R; . cmoAru.ic aoccsoeara,ie a,c e3a34e40,05 5228384410 5281 Acaoibrdsgsoa,rn pitcfi aotcnto;y m pcoaulcnidtso;ni n syhnuthmeasni s, de3ri4v0a6t1i5ve4s , 3406241 oopalvrieegrnovtnieuercwal;le otGniuIdt erisdti;is oenar;se evsic,eo wp,p3 e4r30 4607d1e8f10i2 c3i ency, 3402259
rollinecin B; R. mucosa, 3405284 arachidonic acid; pig, rat hearts, 3405265 patient care; death, 3402792
AAcc3ateebo4tsnt0okoo3rin2hpne6ete 1xci ioannm;;i dlUei.;d otcoapnihknaiern,me asic3so4,k0 i5n39e49t03i5 c2s8;6 kidney failure, ddebroelaudosdcoecridcoce as nnaolaohelciveeiecxdul ,eks n;oa ocdcioyircmdse ;bdt i ranoabcabplitshodiooysro;d,pn t,pic 3ieogl4nol,0,l 0 erim1ac3e5t 4 m50a,bhc5e ria7adr31;nt4 9se0, s 6,13 34130 450246352 2 ppppeahe3dtan4iirtae0matn4amrt3cii 4cedis3uin; tn fieocr raemvliais teeiwtco,hani r;oe ;n3 a4pt0hhe4e;ya 3sl2itpc8hhi laencba irteci os,nt seua3lm4t,a0 t0i83o14n6,0 4823
dissolution; acetaminophen, 3405058 fish oil; IGA glomerulonephritis, 3406635 pharmacy, community; role, 3404096
mreiscirdousepsh; ergeesl;a ticno mmpiacrriossopnhse,r es3,4 0324308660 54 glilnyocleeriycl amciodn;o opliega,t er;at vheeahritcsl,e s,3 43045020653 00 pprroipmhayqluaixnies;; inneteedrlaec tieonxsc,h an3g4e0,2 32374 05341
aemspoehmltevaneb ynottlosiai;tn Fe,s r;i b3o4rf0al5t a0ivo9is.On, , 33440055205 547 eee effects; opsllub3eacii4nrcot0o st0s;re2a a c9nic5sdof,;fan tottera3ynmb 4tas,a0to c2irio4p3dnt0 4,i40e o s5nt3,3e 04rs073;1 4302s5p47a;1r 9fl;vo exhaiccliens , gr3a4nu0l0e2s5,4 qrppuery3asor4letiia0emtra1eycs0 hte3;h o0 af im anilnhinitfebiei;;-t toiorcnxsso;oo pmmlbpnairisnoamte, od c ao3nl4ttshi0,eb 2ro7ad38pi4y3e0,s 1 ,6 344130;43 023r60e27v1 i ew,
topical preparations; stratum corneum, 3405161 ritonavir, kidney failure, 3404161; overview,
Acheitiy l PiS gi OPhTi midSeI,E see Trichosanthes hupehensis; essential oils, 3401957 3406762
Acetyl- 5-aminosalicylic acid; chromatography, vehicles; halofantrine, 3400253 so3m4a0t5r1o4pi5n ; HIV wasting syndrome, 3404975,
SN-ilAisqocubeaiutdt;yy l1lt-5 i Lsc-siauterr pagotilelen,vy yemllsos-e,reL p -h3pIi4rRs0oIm2-l;56y 79!75-H LI-Va spinafretcytilo-nNs,H - cAAiccbptsiioso-ttxodAriracyecizii atattsindyrinio;se sl,tt iavrnsiu3,tbl4 ;uv0 tos1iev1ooean5v g,4e iI,rns v3aoi4al3ec0 w4i6,0tc2 4ra1en436td34ii 2d0n i 2a2s8i9s, 3400117 ssstuoawalmvavfaasuiattdlmriiaeonbntpigehli; ion txs yayr,aezn vnodid3lre 4eow,0m,i 0en 4s,c93u ol64im;03nb 14-il00nti64aok39tex 7 io6opgn lr,ao swmttihrci mfeeatnchctoeopprh raiIlm;i; t HiIs,V
thioph see 1-Benzo[b]thien-2- Aclarubicin 3403207
release; microspheres, 3402239 therapy; M. avium complex, 3400973; Kaposi's
ALc-3eA4tc0ye6lt8-y0Ll1-c caarrnniittiinnee;, Asleze heLi-mAecre’tsy ldciasrenaiste;i ner eview, Acetnermeypt ehrraotmuyrcei;n , er3y4t0hr1o8c1y2t e membranes, 3405070 wvaoscmacericnnoe;ms a;, e ppir3do4ed0mu1ic7ot6l 1od geyv,e lo3p4m0e6n3t6,5 3406515
Acetyicellulose, see Cellulose acetate isotretinoin; subsidization, 3401432 zalcitabine; combined therapy, 3402310
Acetylcholine; receptors; nicotinic, 3402516 therapy; adolescents, 3401075 zidovudine; combined therapy, 3402310; small-
Acetylcysteine Acne vulgaris cell lymphoma, 3404192
combination, tuaminoheptane sulfate; azelaic acid; overview, 3404359 Acquired immunodeficiency syndrome vaccines,
comparisons, 3405925 folk medicine; comparisons, 3403582 see AIDS vaccines
interactions; cefpodoxime proxetil, 3404216 skin and mucous membrane preparations; OTCs, Acridones
therapy; acetaminophen overdose, 3405228; M. 3405139, 3406724; overview, 3406659 Citrus species; antivirals, 3401978
pulegium toxicity, 3403555 therapy, 3402474 Yalaha species; structures, 3401955
Acetylcysteine sodium; incompatibilities; artificial Aconitine Acrimarine F; Citrus species; antivirals, 3401978
tears, 3405097 combination, hypaconitine, meaconitine; LC, Acrodontiolamide; effects; cytotoxic,
N-Acetyicysteine, see Acetylcysteine 3403852 antimicrobial, 3402503
2-Acetyl-2-decarboxamidooxytetracycline; combination, hypaconitine, mesaconitine; TLC- Acrodontium salmoneum; acrodontiolamide;
isolation; oxytetracycline, 3404855 533 cytotoxic, antimicrobial effects, 3402503
4'-Acetyl-2'-(2,4-difluorophenoxy) Aconitum carmichaeli; toxicity, 3401943 Acrylates
methanesulfonanilide, see FK-3311 Aconitum kirinense; diterpenes; isolation, patches transdermal; fentanyi, 3402381
—— Digitalis lanata; extraction, 3400519 polymers; film coatings, 3406449
3402210 Aconitum kusnezoffi; toxicity, 3401943 Acrylics; coatings; capsules, 3402405
B-Acetyldigoxin; interactions; pantoprazole, Aconitum lostapfianum; diterpenoid 4-Acryloylmorpholine; copolymers; p-nitrophenyl
3403630 alkaloids; identification, acrylate, 3404252
O-Acetyljervine; Veratrum album; beta agonist Aconitum species N-Acryloylmorpholine, see 4-Acryloylmorpholine
activity, 3403346 alkaloids; LC, 3403852 Act 3, see Ibuprofen
International Pharmaceutical Abstracts
Actidose-aqua Subject Index
Actidose-aqua, see Charcoal activated nutrition, 3405863; particulate contamination, health maintenance organizations; disease
Actilyse, see Alteplase 3405555; pH, 3403712; pharmacy compounding, management, 3400639, 3403503; U.S., 3403502
Actinomycetes; media; antibacterial effects, 3402043; propofol-thiopental incompatibilities, home health care; Great Britain, 3404015;
3400412 3400333; teniposide sang omen, 3405562; injections, 3402070
Actiprofen, see Ibuprofen — incompatibilities, 3400335; TP’ hospital pharmacy; ADR programs, 3405636;
Activase, see Alteplase 3400349; TPN contract services, 3405622; adverse reactions reports, 3401583; allergy
Actovegin; diabetes mellitus; non-insulin- tekdae 3400330 documentation, 3405486; antibiotic prophylaxis,
dependent, 3403576 sodium chloride; fluorouracil incompatibilities, 3405489; anti-emetic comparisons, 3405618;
Acular, see Ketorolac tromethamine 3402443 antineoplastic agents, 3404889; antineoplastic
Acyclouridines; research; synthesis, 3404424 Adefovir; HIV infections; pharmacokinetics, prescribing, 3405523; artificial intelligence,
Acyclovir 402599 3405642; automated dispensing, 3405439; bar
chickenpox, 3403606; prophylaxis, 3405861 Adenia globosa; oxytocics; rats, 3405302 codes, 3405478; billing, 3405610; clean room
classification; OTCs, 3403383 Adenia gummifera; gummiferol; antitumor effects, construction, 3405471; clinical information
concomitant therapy, 3405885 3402663 systems, 3405631, 3405632, 3405640; clinical
creams; release, 3402387 Adenocarcinoma; monocyte chemotactic and services, 3405625; clinical skills, 3405528;
cytomegalovirus infections; comparisons, 3406660 activating factor; toxicity, 3401866 clinical supervisors, 3405447; CNS drug
encephalitis; California, 3405691 Adenocard, see Adenosine toxicity, 3405520; code of conduct, 3402895;
herpes zoster; combined therapy, 3402972; Adenosine computer interfaces, 3405633; computer
continuous IV, 3405678; protocols, 3405963 arrhythmia, 3401180; overview, 3403124 programs, 3405435; computerized prescription
herpes zoster ophthalmicus, 3402475 toxicity; sex, 3400211 forms, 3402849; computers, 3405508; continuity
Herpesviridae infections; comparisons, 3400368 Adenosine agonists; 8-styrylxanthines; structure- of care, 3405484, 3405524; contract services,
incompatibilities; TrophAmine, 3400330 activity relationships, 3401281 3403506, 3403507, 3403509; controlled
metabolism; models, 3406226 Adenosine antagonists; 8-styrylxanthines; substances, 3405816; cost savings, 3405601;
overview, 3401807, 3404365 structure-activity relationships, 3401281 data collection, 3401546; discharge consultation,
virus diseases, 3400372 Adenosine deaminase 3405461; dosage protocols, 3405517; drug
wounds and injuries; needlesticks, 3406531 overview, 3404808 administration routes, 3402896; drug allergies,
Acyclovir sodium; incompatibilities; meropenem, structure; bovine, 3404523 3401528; drug information services, 3402190;
3400963 Adenosine triphosphate; concomitant therapy, drug interactions, 3405637; emergency cart
Acylcarnitines; absorption; calcitonin salmon, 3405887 supplies, 3405527; emergency drug
3405046 Adhesion incompatibilities, 3405462; equipment costs,
Adalat, see Nifedipine alcohols, polyvinyl; in vitro, 3405998 3403495; error reporting, 3405440; floor stock,
Adalat retard, see Nifedipine biological, see Bioadhesion 3405487; floor stock errors, 3405452;
N-Adamantyl n-alkanamides; absorption; coatings; capsules, 3402405 formularies, 3401544, 3404013, 3405459; Good
transdermal, 3402358 hydroxypropyl cellulose; in vitro, 3405998 Clinical Practices, 3405591; Great Britain,
Adderall, see Amphetamine aspartate; polymers; buccal patches, 3402394 3405869; group purchasing, 3405623; home
combination, amphetamine sulfate, tamarind seed gum; buccal patches, 3403013; in health care, 3405513, interventions, 3404011;
dextroamphetamine saccharate, vitro, 3405998 investigational drug information, 3405635;
dextroamphetamine sulfate xanthan gum; in vitro, 3405998 investigational drug services, 3405442, 3405443,
i , see Dependence Adhesives 3405444; IV compounding, 3406953; IV
Addicts biological, see Bioadhesives services, 3405485; IV to oral conversion,
attitudes; community pharmacists, 3407048 permeation; amlodipine, 3402384 3406453; IV waste reduction, 3405496; JCAHO,
cocaine; laws, 3403391; phenytoin, 3400196 polymers; patches transdermal, 3402381 3400738; JCAHO pearls, 3405493; laboratory
cocaine hydrochloride; laws, 3403391 Adianiuim species; classification, 3400511 computer interface, 3405638; layoffs, 3400057,
cost benefit analysis; methadone maintenance, Adipex-P, see Phentermine hydrochloride 3405516; layout, 3405472; managed care costs,
3402050 Adjuvants, see Excipients 3402047; material management, 3405433;
diacetylmorphine, 3401427; overdose, 3401387 Administration mechanical ventilation protocols, 3405609;
drug abuse; HIV infections, 3400661, 3405341; American Association of Colleges of Pharmacy; Medicare reimbursement, 3405617; medication
methadone therapy, 3401343; prisons, 3401384; membership, 3404077; recent developments, errors, 3401453, 3403384, 3405451, 3405494,
tests, 3406182 3407029; research, 3407032 3405498, 3405521, 3405592, 3405597, 3405612;
hydrocodone; suicides, 3404997 American Journal of Health-System Pharmacy; medication guides, 3405458; order transcription,
illicit drugs; storage, 3405358 article topics, 3401473 3405519; outsourcing, 3403505, 3403508;
methadone; compliance, 3402824; interactions, American Society for Parenteral and Enteral patient focused care, 3405482; patient outcome
3402326 Nutrition; nutrition support, 3403620 knowledge, 3406471; pharmaceutical care
narcotics; methadone, 3400655, 3400708, Berk Pharmaceuticals; tableting capacity, 3403463 implementation, 3404137; pharmaceutical
3400860 charity; drug donations, 3402746 industry partnerships, 3405505; pharmacy
pain, 3402462 clinical pharmacists; time studies, 3401574 benefit management companies, 3405475,
Addison’s disease clinical studies; ethics, 3403394; multicenter, 3405495, 3405501, 3405512; physician
hydrocortisone, 3400826 3401344; pharmacists role, 3405598 computer entry, 3406421; prescription
thyroxine; toxicity, 3400826 contracts; laws, 3405349, 3405350 copayments, 3405599; prescription indications,
Additives control, quality, 3401519; validation, 3407069 3405468; prescription readability, 3405460;
dextrose; dopamine, heparin incompatibilities, Department of Veterans Affairs; pharmacy professional competence, 3402162; psychiatry,
3402556; fluorouracil incompatibilities, 3402443 services, 3405857; reorganization, 3400083 3400061; quality assurance hotlines, 3405479;
injections; amphotericin B incompatibilities, drug abuse; Olympics, 3400662 quality control, 3403519; quality improvement
3405098; amphotericin B stability, 3405560, drug distribution; Bosnia-Hercegovina, 3402042 strategies, 3403520; re-engineering, 3405470 .
3405564; amphotericin B, 3400334; drug information centers; self directed team, 3405514, 3405526, 3405634; serotonin
antineoplastic agents incompatibilities, 3406598; 3407068 antagonists costs, 3405600; staff development,
bumetanide incompatibilities, 3403720; drugs, see Drug administration 3405454, 3405525, 3405535; standard operating
cefazolin-meperidine incompatibilities, 3403087; drugs, adverse reactions; data collection, 3407082 procedures, 3403521; strategies, 3405877;
ceftazidime-teicoplanin, 3405100; ceftriaxone, education; graduate, 3407030, 3407033; multiple substitution protocols, 3405518; survey,
3400338; ceftriaxone-labetalol, 3400331; choice questions, 3404067; techniques, 3407019; 3404862; technician survey, 3405529;
ceftriaxone-metronidazole incompatibilities, U.S., 3407033 technicians interventions, 3405530; technicians
3403721; cimetidine incompatibilities, 3406068; education, pharmaceutical; curriculum, 3402820; order entry, 3405531; TPN contract services,
cladribine incompatibilities, 3404277; clean educators activities, 3402803; examinations, 3405622; trends, 3405655; turnover, 3400077
room construction, 3405471; compounding, homework, 3404069; hospital hospitals; antineoplastic agents, 3400741; error
3400002, 3400053, 3401485, 3404866, 3406953; pharmacy, 3405395; India, 3404066; instruction prevention, 3404140; ethics decisions, 3403393;
doxorubicin incompatibilities, 3405561; problems, 3404070; introductory practice JCAHO performance reports, 3401995;
elastomeric infusion pumps, 3 “3 experience, 3402811; laboratory exercises, pharmaceutical care, 3404872; pharmacy
emergency drug incompatibilities, 3405462; 3407028; Pew report, 3404799; PharmD services catalog, 3403514; quality assurance,
fentanyl-fluorouracil incompatibilities, 3406602; clerkships, 3402805; problem based learning, 3405871; risk assessment forms, 3402300; :
filgrastim incompatibilities, 3403724; 3402802, 3404076, 3407024; radiopharmacy, therapeutic guidelines, 3404883
granisetron, 3400966; granisetron 3402818; self-assessment, 3402809 India; national drug policies, 3400628
incompatibilities, 3402432; hydromorphone- European Agency for the Evaluation of Medicinal industry; consultants, 3404026; statistics,
midazolam incompatibilities, 3406610; Products, 3401368 3404027; total productive maintenance, 3402773
hydromorphone-promethazine, 3400336; 3 in 1, Food and Drug Administration; approval process, industry, pharmaceutical; benchmarking, 3404018;
3405115; incompatibilities, 3403083, 3403086; 3403973; approvals, 3402016; drug labeling, building costs, 3404016; China, 3403398;
iron dextran, 3406601; IV pharmacy services, 3406930; medical devices approvals, 3403373; consumer attitudes, 3402762; EC, 3402011;
3405485; IV waste reduction, 3405496; new drug approvals, 3406926; reform, 3403372 facility renovation, 3403461; FDA inspections,
ketamine-meperidine, 3403084; levofloxacin Georgia; pediatric immunization, 3406959 3406938; isotretinoin subsidization, 3401432; J.
incompatibilities, 3402433; mannitol-sodium health care; case management, 3401456; Zabriskie, 3404753; mergers, 3404752; politics,
bicarbonate, 3400332; menatetrenone computers, 3404102; England, 3404014; 3402754; process improvement, 3401496;
incompatibilities, 3405116; meropenem professionals, 3405408; technology, 3404101; project management, 3407010, 3407011; quality
incompatibilities, 3400963, 3403722; paclitaxel trends, 3407009 assurance information, 3405822; regionalization,
incompatibilities, 3405557, 3405558; parenteral health care reform; international, 3404779 3402757, 3404756; research, 3407012; role,
1086 International Pharmaceutical Abstracts
Subject Index Advertising
3402769; unlabeled use, 3401994; value 3404866; outpatient dispensing, 3406459; patient Adriblastin, see Doxorubicin hydrochloride
engineering, 3403462 controlled analgesia, 3406719; pharmaceutical Adsorbents
institutions; drug administration routes, 3401573; industry, 3400011, 3402202; pharmaceutical charcoal ovensc sa reeagues, 3402585;
therapeutic, 3401578 representatives, 3402777; pharmacy errors, potentiometry, 3403061
integrated health care; teleconferencing, 3405641; 3405448; prescription drug pricing, 3405356; copper gr — halitosis, 3400304
U.S., 3403502, 3405352; wholesalers services, research, 3404059, 3405792; sterile products diarthea; OTCs, 3406776
3405620 compounding, 3400053 flavonoids; halitosis, 3400304
Japan; health ministry, 3405365 prescribing; health industry number, 3402176 polymers; chlorpheniramine emulsions, 3402416
job performance; staff appraisal, 3406969 purchasing; hospitals, 3400813 Adsorption
Joint Commission on Accreditation of Healthcare quality assurance; DUE, 3401989 additives; phenytoin, 3405093
Organizations; inspections, 3404870 reimbursement; Pharmaceutical Society of South antibodies; capillary electrophoresis, 3402409
leadership; hospital pharmacy, 3405490; Africa, 3404772 betamethasone sodium phosphate; ethylcellulose,
legislation, 3402008; organizations, 3402154; risk management; home health care, 3407039 3402378
pharmacy, 3400677; volunteers, 3406973 schools; admissions criteria, 3402807; pharmacy, bumetanide; polyvinyl chloride, 3403720
legislation; strategies, 3402001 3407027; tenure, 3404075 calcitonin salmon; polyglactin 370, 3403703,
managed care systems; disease management SmithKline Beecham; cimetidine costs, 3401444 3403704
programs, 3405464; economics, 3406966; South Africa; National Drug Policy, 3404724 calcium; sodium polymetaphosphate, 3400315
medical devices, 3403388; physicians, 3400081; state boards; pharmacists role, 3400613 cetylpyridinium chloride; magnesium stearate,
therapeutic substitution, 3400051 United States Air Force; pharmacy services, 3406549
management; therapeutic outcomes, 3404374 3405858 charcoal activated; protein binding, 3402693;
Medicaid; pharmacists role, 3400706; prior United States Army; pharmacy services, 3405859 theophylline, 3402913
authorization, 3401435 United States Navy; pharmacy services, 3405860 chlorpromazine hydrochloride; kinetics, 3400316;
medical devices; planning and design, 3403371, United States Public Health Service; pharmacy potentiometry, 3403061
3403374, 3406932 services, 3406394 cholesteryl oleyl carbonate; albuterol, 3404244;
National Health Service; interferon beta protocols, Wisconsin Society of Health-System Pharmacists; pyroxylin membranes, 3402374
3403600; reform, 3401440 vision statement, 3405. colony stimulating factor; incompatibilities,
organizations; injections, 3401506 World Health Organization; essential drugs, 3404280; polymers, 3400917
partnerships; hospitals, pharmaceutical industry, 3401372 CT-15; polyglactin 370, 3403703, 3403704
3406388 Administration sets, see Surgical supplies; dimethy! sulfide; flavonoids, 3400304
patient information; confidentiality, 3402007 administration sets drugs; administration sets, 3405863; «-
personnel; guidelines, 3400651 dministrators carrageenan, 3406021
personnel, pharmacy, 3404085; computer attitudes; staff appraisal, 3406969 flavors; plastic containers, 3405826
programs, 3404839; laws, 3404715, technicians, guidelines; personnel, 3400651 isotherms; epidermal permeability, 3405170
3402020 hospital pharmacy; contracts, 3401563; Great ketotifen fumarate; water, 3403070
pharmacists; independent contracting, 3402140; Britain, 3405869; layoffs, 3400057; outpatient lysozyme hydrochloride; containers, 3401742
interviews, 3402159; job description, 3402147; dispensing, 3406459; pharmacy school magnesium; sodium polymetaphosphate, 3400315
reimbursement, 3404772 relationships, 3404783, 3404785, 3404786: methamphetamine hydrochloride; charcoal
pharmacists, community; paperless claims, supervisors, 3405447; trauma care, 3400805; activated, 3402585
3406409; pharmaceutical care, 3402812; turnover, 3400077 methyl mercaptan; flavonoids, 3400304
strategic alliances, 3400704; technician industry, pharmaceutical; managing directors, norfloxacin; polarography, 3406860
supervision, 3406397 3404720 paclitaxel; incompatibilities, 3405558; plastics,
pharmacists consultant; time studies, 3406460; pharmacists; future, 3402127 3405557
warfarin management, 3404150 pharmacy; practice innovation, 3405490; role, phenylmercuric nitrate; complexes, 3406065
pharmacists, hospital; cooperation improvement, 3404881 polyamino acids; herbicides, insecticides, 3401719
3403528; ethics, 3405351; H. pylori clinic, pharmacy, community; ownership, 3406995 polyglactin 370; peptides, 3403704
3404078; sterile products, 3400621 technicians; hospital pharmacy, 3400089 polymers; herbicides, insecticides, 3405085
pharmacy; automation, 3400014; computer Admixtures, see Additives; injections poly(sodium 4-styrenesulfonate); iron oxide,
software, 3404840; drug cost projections, Adolescents 3403696
3403385; managed care systems, 3401534; acne, 3401075 propranolol hydrochloride; kinetics, 3400316
practice, 3403437; theses, 3404794 alcohols, ethyl; consumption, 3401382 quinidine hydrochloride; kinetics, 3400316
pharmacy benefit management companies; patient anabolic agents; education, 3403392 quinine hydrochloride; kinetics, 3400316; sodium
care, 3401396 asthma; peak flow monitoring, 3404396 polymetaphosphate, 3400305
pharmacy, community, 3402837; antitussive sales, attention deficit disorder with hyperactivity, sodium benzoate; water vapor, 3400568
3402072; cognitive services, 3402827; computer 3406091 sodium polymetaphosphate; calcium, magnesium
programs, 3407073; Hungary, 3404813, behavioral and mental disorders; review, 3401053 ions, 3400315; kinetics, 3400316
opportunities, 3400734; ownership, 3406939, contraceptives; sociology, 3402298 sulfasalazine; sucralfate, 3400287
3406990; pharmaceutical care, 3403430; depression, 3401782 tetradecylpyridinium; silicas, 3406048
purchasing, 3402836; third party debt, 3404765; drug abuse; Great Britain, 3401389; survey, trimethylamine; flavonoids, 3400304
third party programs, 3402848; wholesaler loans, 3405353; U.S., 3400645; UK, 3401383 triptorelin; polyglactin 370, 3403703, 3403704
3406994 epidemiology; cigarette smoking, 3400665 vapreotide; polyglactin 370, 3403703
pharmacy, institutional; ambulatory care services, epilepsy, 3406100 Adulteration
3405441; clinical training, 3405393; financial folic acid; dosage, 3404317 MDMaA,; tablets, 3401385, 3401386
management, 3404745; formularies, 3405480; hepatitis A vaccines; toxicity, 3400145 Adverse DrugR i 1583
industry partnerships, 3405605; integrated health hepatitis B; immunization, 3406711 see also 3400004, 3400024, 3400181, 3400591,
care, 3405621; JCAHO, 3406933; layoffs, hypertension; review, 3402450 3401528, 3401555, 3401597, 3401942, 3402319,
3401577; LTCF, 3400595; mail order, 3406455; methotrexate; asthma, 3406702 3402467, 3402692, 3402926, 3402931, 3402961,
OTCs, 3405503; pharmacists interventions, polio vaccines; utilization, 3402745 3402985, 3403691, 3403974, 3404867, 3404894,
3405499 smoking, 3406364; cessation, 3405370; 3405429, 3405486, 3405592, 3405636, 3405714,
pharmacy services; ambulatory care, 3405445, pharmacists role, 3406362 3405772, 3405786, 3406467, 3406525, 3406918,
3405536; anticoagulation clinic, 3405488; tetanus vaccines; utilization, 3402745 3407080, 3407082
cerebrovascular disorders, 3405492; geriatric vaccines; protocols, 3406621 Adverse drug reactions, see Drugs, adverse
outpatient firms, 3405476; health benefit varicella vaccines; CDC protocols, 3400166 reactions
programs, 3400804; immunization programs, Adrenal cortex extract; toxicity; M. abscessus, Adverse reactions, see Drugs, adverse reactions
3407013; integrated health care, 3405450; 3405903 Advertising
managed care systems, 3405449; outpatient Adrenal gland hypofunction; review, 3400361 alpha-hydroxy acids; industry claims, 3401400
formularies, 3405459; pharmacokinetics, Adrenaline, see Epinephrine angiotensin converting enzyme inhibitors; toxicity,
3400801; pharmacotherapy clinics, 3405491; —_— hydrogen tartrate, see Epinephrine 3406509
primary care, 3405455, 3405511, 3405522; bitartra consumers; drug purchasing behavior, 3404761;
protocol implementation, 3405483; quality Pr mre _— see Sympathomimetaigce n C, 3400617
improvement, 3401579; smoking cessation ——" blocking pte regseee upanebee” drugs; consumers, 3401409; cytochrome P-450,
clinics, 3405481; telemedicine, 3405534 3402806; India, 3401475; Internet, 3406930;
policies and procedures; AJHP, 3404103; a steroids, see Steroids, cortico- self-medication, 3400678; unlabeled use,
antibiotic protocols, 3404159; antibiotic Adrenocorticotropic hormone, see Corticotropin 3401994; women, 3401374
utilization, 3404155, 3404778; antibiotics, Adrenoleukodystrophy ephedrine, 3406330
3404777; controlled substances, 3405453; drug erucic acid, combination, oleic acid, 3400155, histamine H2 antagonists; pharmacists attitudes,
abuse, 3405778; drug information, 3400757;
drug misuse, 3401433; essential drugs, 3402095; Adrenolytic agents, see Sympatholytic agents history; France, 3406337; ointments, 3402735
FDA, 3403376; health care, 3403411; health Adriacin, see Doxorubicin hydrochloride ibuprofen; OTCs, 3402772
care reform, 3401442; hospital pharmacy, Adriamycin industry, pharmaceutical; FDA, 3402709;
3400001; hospitals, 3403523; e-mail, 3407066; see Doxorubicin metronidazole, 3406351
medical schools, 3401455; medicinal plants, see Doxorubicin hydrochloride journals; needlestick prevention devices, 3405828
; Meperidine utilization, 3404138; Adriamycin hydrochloride, see Doxorubicin perfumes; strategies, 3404770
needlestick injuries, 3402899; needlesticks, hydrochloride pharmacy; history, 3404730; Romania, 3404814
International Pharmaceutical Abstracts 1087
Advertising Subject Index
pharmacy, community; drug interactions, administrators; hospital pharmacy, 3400077 Aggregation
3402697; Internet, 3402167 adolescents; vaccine utilization, 3402745 albumin bovine; NMR spectrometry, 3404528
prescription drugs; costs, 3405356 consumers; cigarette smoking, 3400665; olfaction diazepam; dissolution, 3402397
prescriptions; consumers, 3402084, 3406370; effects, 3406625; OTC risk perceptions, dolasetron mesylate; solutions, 3402396
direct to consumer, 3407005 3402786 dornase alfa; thermal stability, 3400968
television; prescription drugs, 3402846 geriatrics; anticoagulant toxicity, 3402263; beta drugs; particle size, 3402201
tobacco; adolescents, 3401389 blockers, 3405692; pharmacokinetics, 3405230; endotoxins; ultrafiltration, 3404125
toremifene citrate; toxicity, 3406975 phenytoin, 3400474; self-medication, 3401626 globulin immune; NMR spectrometry, 3404528
Advisory Committee on Immunization Practices, isoenzymes, 3401906 interleukin 2; reconstitution medium,
see United States Public Health Service; neonates; gentamicin, 3401905 liposomes; immuno-enzymosome prodrugs,
Advisory Committee on Immunization Practices patients; acetaminophen blood levels, 3406220; 3405074; N-stearyl lactobionamide, 265
Advisory Council for the Elimination of adult immunization, 3403748; adult somatropin MDL-201346A; solutions, 3406020
Tuberculosis; BCG vaccines; protocols, 3403612 deficiency, 3400982; antidepressants utilization, microspheres; nifedipine release, 3404232
Aeroplysinin I; Aplysina aerophoba; cytotoxic 3406537; antimanic agents, 3405705; busulfan molecules; dispersions, 3402415
effects, 3406771 pharmacokinetics, 3406133; calcium, 3403100; montelukast sodium; self-association behavior,
Aerosil 200, see Silicon dioxide colloidal cholera vaccines, 3405935; clinical monitoring, 3406032
Aerosol OT, see Docusate sodium 3400075; community-acquired pneumonia, pellets; coatings, 3406446
Aerosols 3403613; dextran 40, 124; diltiazem, ribonuclease; reconstitution medium, 3400940
albuterol; comparisons, 3405076; status 3402586; docetaxel, 3406914; dosage protocols, urokinase; thermal stability, 3406064
asthmaticus, 3402903 3405517; ear temperature, 3405827; growth Aging
albuterol adipate diethanolate; comparisons, hormone deficiency, 3404969, 3405145; HMG- cell culture; Caco-2 cell monolayers, 3403947
5076 CoA reductase inhibitors, 3405229; hypnotics, drug interactions, 3403134
albuterol stearate; comparisons, 3405076 3401630; interferon alfa, 3402982; laxative errors, medication; compliance, 3402137
albuterol sulfate; comparisons, 3405076 comparisons, 3400818; lithium, 3405022; hyaluronic acid; skin, 3401758
—" B; aspergillosis prophylaxis, methotrexate, 3401926; methotrexate therapy, melatonin; effects, 3401224
50 3406702; mirtazapine pharmacokinetics, pharmacy services, 3404818
Pa a “devices, 3402199; overview, 3400996; 3406648; nimodipine, 3406222; NSAIDs, prasterone; overview, 3403110
pharmaceutical care, 3405628; review, 3405739 3404782; opiate pharmacokinetics, 3405236; propanedial; autoantibodies, 3400435
budesonide; croup, 3401151 pantoprazole, 3403876; pharmaceutical care, Shengi; folk medicine, 3403772
deoxyribonuclease; lung diseases therapy, b pharmacoeconomics, 3403180; skin; UV — 3401819
3403155 policosanol, 3403571; psychotherapeutic agents Aglaia odora yc
epinephrine; croup, 3401151 toxicity, 3400142; quinolones, 3400127; po ret activity, 3402631
estradiol; nasal absorption, 3403672 respiratory tract infections, 3401852; review, A gran
flunisolide; inhalers vs nebulizers, 3405239 3401147; rocuronium pharmacokinetics, amikacin; comparisons, 3404204
fluticasone propionate; asthma, 3402463 3401303; simvastatin, 3404012; theophylline, ceftazidime; comparisons, 3404204
N&-monomethyl-L-arginine; asthma, 3400146 3404627; thrombocytopenia risk factors, meropenem; comparisons, 3404204
inhalers; aerodynamics, 3401713; water 3406619; thyroxine overdose, 3402915; ticlopidine; toxicity, 3401592
permeation, 3401352 tiaprofenic acid pharmacokinetics, 3406214; ticlopidine hydrochloride; toxicity, 3400107
insecticides; toxicity, 3405669 tolrestat, 3404618; valacyclovir, 3406687; ippal, see Influenza vaccines
ipratropium bromide; rhinorrhea, 3404348; status vancomycin protein binding, 3405768; warfarin, Agrocybe cylindracea; constituents; antineoplastic
asthmaticus, 3402903 3404208 effects, 3402652
models; flow, 3406312 pediatrics; antibiotic utilization, 3400857; AIDS, see Acquired immunodeficiency syndrome
morphine; dyspnea, 3403619 Bayesian forecasting, 3405320; drug AIDS vaccines
morphine sulfate; SL suspensions, 3405040 information, 3403205; famotidine, 3403259; effects, 3405914
nebulizers, 3402389 fever, 3403764; theophylline compliance, immunogenicity; rgp 120, 3401609
nicotine; smoking cessation, 3406089 3404210; tiaprofenic acid pharmacokinetics, research; product development, 3406515
nitric oxide; toxicity, 3404170 3403262 AIDS-related complex; zidovudine; interactions,
norflurane; quality control guidelines, 3403992 pharmacists; careers, 3404092; hours, 3407036 3401668
oligonucleotides; lung absorption, 3401916 pharmacists, hospital; ASHP membership, Air
overview, 3401494 3400052 contamination; settle plates, 3400776
particle size, 3401512 scientists; pharmaceutical industry, 3406957, flow; integrity tests, 3404846; laboratory
patient information; administration, 3405507 3406961 ventilation, 3406423
propellants; chlorofluorocarbon alternatives, students; drug abuse, 3405353; technicians, laboratories; building design, 3406427
3400791; metered dose inhalers, 3406433 3406393 toxicity, environmental; asbestos, 3403968
solvents; packaging, 3403483 tamoxifen citrate; pharmacokinetics, 3405247 Airway obstruction; angiotensin converting
terbutaline sulfate; stability, 3402434 valproic acid; protein binding, 3400477 enzyme inhibitors; toxicity, 3402914
triamcinolone acetonide; asthma, 3406082 women; AIDS epidemiology, 3406365; hormone juga lupulina; neoclerodane diterpenoids;
United Kingdom; volatile emissions, 3401486 replacement therapy, 3402966; oral contraceptive antibiotic activity, 3402628
mimosifolia; constituents, 3402647 use, 3404990; oral contraceptives toxicity, Ajugoside; Sideritis libanotica; isolation, 3405305
3404914, 3404915 Alacepril; hypertension, 3406516
proanthocyanidin A >; antioxidant activity, zidovudine; pharmacokinetics, 3403275 [D-Ala*]Gonadorelin; metabolites; rabbit mucosa,
3403690 Agelas novaecaledoniae; alkaloids; isolation, 3402603
venous insufficiency; comparisons, 3404950 53.4 0468: 6 D-Alanine; effects; p-coumaroylamino acid
A ; Salvia aethiopis; isolation, 3403340 Agency for Health Care Policy and Research accumulation, 3402669
AF-2259; complexes; cyclodextrins, 3405824 guidelines; urinary incontinence, 3400877 Alanylglutamine; parenteral nutrition;
AF-64A, see Ethylicholine aziridinium Office of the Forum for Quality and Effectiveness supplementation, 3401257
Afebril, see Acetaminophen in Health Care; overview, 3402035 L-Alanyl-giutamine, see Alanyigiutamine
Affective disorders; lithium carbonate; protocols; controversies, 3402036; otitis media =, Cassia tora; radical scavenging effects,
equivalency, 3401628 with effusion, 3406538
Aflatoxins; Aspergillus flavus, 3403298 United States Public Health Service; pharmacy Albendazole; echinococcosis; monitoring, 3404959
Aframomum melegueta services, 34063 Albenza, see Albendazole
constituents; antimicrobial, 3406115 Agency for Toxic Substances and Disease Albizia gummifera; budmunchiamines; antibiotic,
ulcers; rats, 3405303 Registry; United States Public Health Service; antineoplastic activity, 3402619
Africa pharmacy services, 3406394 Albumin
folk medicine; prostatitis, 3403315 Agglomerates egg; aggregates, 3400038
plants; perfumes, 3406887 pellets; granulations, 3402869 microspheres; etoposide, 3406004
travel; antimalarial agents, 3403540 sodium cholate; fractal analysis, 3404847 Albumin bovine
zidovudine; cost benefit analysis, 3400658 Agglomeration binding, 3406238
After hours service, see Hours; after hours clemastine fumarate; granulations, 3405843 complexes; triamcinolone, 3403244
service microcapsules; composite polymer coatings, effects; lysozyme adsorption, 3401742
AG-1343, see Nelfinavir mesylate 3403697 encapsulation; delivery systems, 3405653
AG-337; administration systems, 3400300 talc; properties, 3400302 liposomes; encapsulation, 3403684
Agarospirol; effects; CNS depression, 3404677 temperature; melt pelletization, 3405837 microspheres; nifedipine optimization, 3406034
Agarwood, see Aquilaria malaccensis Aggregates release, dextran hydrogels, 3403053;
Agastachye rugosa; agastaquinone; isolation, amiloride hydrochloride; incompatibilities, microencapsulated liposomes, 3404231;
3403926 3406067 microparticles, 3404233; microspheres, 3406010
Agastaquinone; Agastachye rugosa; isolation, bile salts; and phospholipids, 3400938 spectrometry, nuclear magnetic resonance;
3403926 colistin sulfate; microencapsulation, 3400038 molecular mobility, 3404528
Agathosma betulina; perfumes, 3406887 furosemide; incompatibilities, 3406067 toxicity; skin tightening, 3404460
Agave lecheguilla; extracts; antimicrobials, lecithin; and bile salts, 3400938; retinoid Albumin human
3403319 solubilization, 3406591 binding; benazepril, benazeprilat, 3403885; food
Age sodium taurocholate; retinoid solubilization, dyes, 3405257; methohexital sodium, 3404273;
addicts; diacetylmorphine overdose, 3401387 3406591 YH-439, 3402597
1088 International Pharmaceutical Abstracts
Subject Index Allergies
body distribution; comparisons, 3400906 interactions; acetaminophen, 3403623; Alfentanil hydrochloride; body distribution;
carriers; drug transport, 3404239 antiparkinson agents, 3400222; cocaine, pulmonary, 3406879
contamination; viral infectivity, 3404928 3403268, 3405979; diacetylmorphine, 3401387; Alginate, see Alginic acid
dissociation constants; berberine chloride, disulfiram, 3406543; estradiol, 3403622 Alginates
iontophoresis; methodology, 3406901 gastroesophageal reflux, 3401227; review,
microspheres; magnetic, 3401710 metabolism, 3403870; pediatrics, 3401317 3406215
recombinant; ligand binding, 3404615 micelles; ester hydrolysis, 3402406 gels; acetaminophen permeation, 3402370
stability; alteplase, 3401524 microspheres; comparisons, 3402386 wound healing; dressings, 3403030
Albumin lactosaminated; carriers; antivirals, mortality; Chinese, 3405936 Alginic acid
3403263 patient information; hospital pharmacists, antacids; review, 3401240
Albuterol 54; nurse run clinics, 3406344 coatings; microencapsulated liposomes, 3404231
aerosois; comparisons, 3405076 permeation; aminopyrine, 3405988; rat skin, gastroesophageal reflux; overview, 3401038
anaphylaxis, 1 3400267 matrices; sustained-action medications, 3400329
asthma; pediatrics, 3405688 pharmacokinetics; geriatrics, 3405230 microcapsules; rotavirus vaccines, 3402372
binding; mucus glycoproteins, 3406238 poisoning, 3402268 Alglucerase
concomitant therapy, 133, 3401584, 3401594, smoking; cessation, 3401270 distribution; patient assistance program, 3402111
3401596, 3405014, 3406503, 3406511 solvents; parenteral formulations, 3402376; Gaucher’s disease, 3402476, 3403154; overview,
inhalers; deposition, 3405084 zileuton, 3402444 3401828; pulmonary hypertension, 3404972
status asthmaticus; oxaprozin reactions, 3402903 sorption; tocopherol, 3403706 pharmacokinetics, 3406212
toxicity; emergency room visits, 3404894 toxicity; dementia, 3400987; gastrointestinal os see Protocols; algorithm:
Albuterol adipate te; aerosols; hemorrhage, 3404919; geriatrics, 3403553; Trimeprazine
comparisons, 3405076 hangovers, 3405891; macrocytic anemia,
Albuterol stearate; aerosols; comparisons, 3406628; pediatrics, 3400824 tase; immunoassay; enzyme,
3405076 transport; oligonucleotides, 3403656
Albuterol sulfate vehicles; flunisolide nebulizers, 3405239; skin Alkalinizing agents
absorption; iontophoresis, 3406564 permeation, 3403020; taxane formulations, sodium bicarbonate; acidosis, 3400138, 3405668;
aerosols; comparisons, 3405076 3403212 emergency kits, 3403512; heart arrest, 3403537;
asthma; comparisons, 3400204 withdrawal; clonidine, 3405738, 3406800; incompatibilities, 3400332
microcapsules; release, 3406023 dopamine neurotransmission, 3403197; review, sodium hydroxide; dopamine, 3400739
overdose; patient consultation, 3401414 3401203 Alkaloids
particle size distribution; inhalers, 3404242 Alcohols, isopropyl O-acetyljervine; beta agonist activity, 3403346
permeation; membranes, 3404244; drying; microcapsules, 3406051 aconitine, combination, hypaconitine, meaconitine;
thermoresponsive membranes, 3402374 poisoning, 3402268 LC, 3403852
release; e! ytes, 3400962; Gelucire matrices, solvents; coprecipitates, 3406061; theophylline, aconitine, combination, hypaconitine,
3402412: matrix tablets, 3401717; sustained- mesaconitine; TLC-LC, 3404533
action tablets, 3401725 Alcohols, methyl Anona species, 3400544
spectrometry; tablets, 3402567 absorption; inhalation, 3400902 aporphines; LC, 3403837
Alcohol ts; naltrexone; alcoholism, extraction; D. lanata, 3402210 berberine chloride; dissociation constants,
3406703 poisoning, 3402268 3400498
Alcoholism solutions; incompatibilities, 3402438 berberine sulfate; absorption, 3400271
acamprosate, 3400200 solvents; residual, 3402878; riboflavin, 3405057; bisbenzylisoquinolines, 3403204
acetaminophen; liver toxicity, 3403623 sulfamethoxazole-trimethoprim, 3406593; Citrus species; antivirals, 3401978
geriatrics; diagnosis, 3404748 theophylline, 3405069; topical preparations, (+)-costaricine; antiplasmodial effects, 3405274
literature; overview, 3401070 3405725 Cryptolepis sanguinolenta; isolation, 3404681
naltrexone, 3406703 toxicity; hangovers, 3405891 ellipticine; fluorometry, 340461 1
patient information; nurses, 3406986 Alcohols, octyl Heliotropium curassavicum; pyrrolizidines,
patients; emergency rooms, 3404145 partition coefficients; complex coacervates, 3400537
Alcohols 3402371; water, 3400959 jineol; antineoplastic activity, 3406271
emulsions; micro-, 3402521, 3403064 solvents; [Nle4D-Phe 7]-a-mel yie leishmaniasis, 3406277
poisoning, 3402268 hormone, 3406027 Lupinus albus, 3400551
reactions; ebselen, 3403803 vehicles; psoralen lipophilicity, 3400566 lycaconitine; synthesis, 3402516
sorption; tocopherol films, 3403706 pentyl; emulsions; sunscreens, 3403741 marine; sponges, 3404686
structure-activity relationships; branching, Alcohols, phenylethyl; extraction; techniques, Nauclea diderrichii; antiparasitic effects, 3403320
3400769 protopines; aldose reductase inhibitors, 3402654
surface active agents; microemulsions, 3406029; Alcohols, polyvinyl research; antivirals, 3401213
tetramethyldioctyldisiloxane, 3406056 absorption; ocular, 3406003 Solanum sepicula; isolation, 3401977
suspensions; metronidazole, 3403716 adhesion; comparisons, 3405998 structure-activity relationships; biological,
vasculyne; acetylenic, 3406284 carriers; DNA plasmids, 3400904 3404395
vehicles; piroxicam gels, 3403014 effects; mucoadhesive polymers, 3403668; teas; HPLC, 3400439
Al yl; herpesvirus infections; review, sulfadiazine microcapsules, 3401522 Tinospora species, 3405300
excipients; ofloxacin implants, 3403071 Trapa natans; isolation, 3403309
Alcohols, benzyl incompatibilities; acetylcysteine, 3405097 Alkanediamines; structure-activity relationships;
excipients; labeling, 3405659; properties, 3406578 matrices; verapamil absorption, 3402355 platelet inhibition, 3403165
toxicity; neonates, 3400838 microparticles; polyglactin 370, 3404233 B-Alkylamino-(4’ -alkyl)-propiophenone
Icohols, butyl Alsctoabhiollisz,er s;p ronpanyo particles, 3406447 derivatives; synthesis; antilipemic activity,
emulsions; micro-, phase diagrams, 3403680 3400420
permeation; rat skin, 3400267 emulsions; micro-, phase diagrams, 3403680 6-Alkylamino(7’-methy!)-propio-2’-naphthone
cetyl permeation; rat skin, 3400267 derivatives; synthesis; antilipemic activity,
excipients; properties, 3406578 Alcohols, stearyl 1 3400420
granules; aminophylline, 3405079 granules; aminophylline, 3405079 Alkylating agents, see Antineoplastic agents
plasticizers; a 3402359 vehicles; fluocinolone, 3405719 Alkylation; 2-arylamino-6-tert-buty}- | ,4-
Alcohols, ethy’ Alcyonium aureum; diterpenoids; antitumor benzoquinones, 3401869
absorption enhancers; iontophoresis, 3406006 effects, 3402661 Alkylglycosides; stability; liposomes, 3403093
abuse; adolescents, 3401383, 3401389, 3405353; Aldehydes; Melissa officinalis; bentazon, 3403332 Alkythalides; reactions; 2-arylamino-6-tert-butyl-
geriatrics, 3404748; students, 3406976 aia 1,4-benzoquinones halogenation, 3401872
alcoholism; acamprosate, 3400200 [1,2,4]triazines; synthesis, 3406843 [2-(Alkyloxy)phenyl]-2-(1-piperidinyl)ethy!
antidotes; hospital pharmacy, 3402898 Aldose reductase inhibitors carbamic acids; structure-activity relationships;
blood levels; laboratory tests, 3402580 Polygala arillata; constituents, 3401961 local anesthesia, —
cardiovascular diseases; insulin sensitivity, ponalrestat, 3406193 pectrometry, 3401885
3402456 product development; overview, 3401275 pier mana ceerecanh user or wT
concentration; amlodipine flux, 3402384; gelatin , Protopines; G.a , Ap cosmetics; properties, 3404356
capsule coatings, 3402213; ketoprofen 1-Alkyl-2-pyrrolidones; fluidization; stratum
hydrogels, 3400318; skin permeation, 3400247 Alendronate sultans corneum, 3402383
concomitant therapy, 3400112, 3404921 new drugs; overview, 3404423 (ali trans)-2,4,6,8,10,12-Tetradecahexene-1,14-
consumption; adolescents, 3401382 osteoporosis, 3401262, 3401230 dial; Conidiobolus paulus; antibacterial activity,
crystallization; sodium cholate, 3404847 overview, 3401128, 3401160 3404654
dependence; naltrexone, 3406703; OTCs, 3401407 therapy; overview/01042, 3401159 Allegra, see Fexofenadine hydrochloride
diluents; docetaxel incompatibilities, 3406600 toxicity; esophagitis, 3400101, 3400103 Allergens; asthma; bronchoprovocation, 3406308
dosage; acitretin distribution effects, 3406216 Alendronic acid Alle:
drugs, over-the-counter; labeling, wee fractures; postmenopause, 3405953 antibiotics, 3406480
emulsions; micro-, phase diea e osteoporosis, 3405159; overview, 3404325, antihistamines; interactions, 3400237
impurities; busulfan, 34013 so sou al 3404390 antineoplastic agents; nurses role, 3402467
3400048 Alfentanil; pharmacokinetics; review, 3405236 azathioprine; adverse reactions, 3404891
International Pharmaceutical Abstracts
Allergies Subject Index
bacitracin; comparisons, 3400181 overview, 3401160 overview, 3401807
bites and stings, 3401016 Altace, see Ramipril therapy; history, 3400372
2-bromo-2-(bromomethy]) pentanedinitrile, A Amarogentin; effects; leishmaniasis, 3402609
combination, phenoxyethanol; dermatitis, approvals; new indications, 3406793 Amaryl, see Glimepiride
86 cerebrovascular disorders, 3403128, 3405570; Amazon; medicinal plants; Ese’eja Amerindians,
carbamazepine; myocarditis, 3406472 hospital pharmacists attitudes, 3401548; 3400541
clemizole penicillin; pustuloderma, 3402257 overview, 3400378, 3402459; protocols, Amberlite IRA-400; resins; dosage forms,
cross; enoxaprin, heparin, 3402985; mometasone, 3406661
3402904 lyophilization; stability, 3401524
diagnosis, 34055380 myocardial infarction; comparisons, 3400843, photericin B
drug histories; mental retardation facilities, 3404319, 3404978, 3406636; methamphetamine Ambrosia maritima; effects; plasma glucose,
3401597; pharmacy documentation, 3405486 toxicity, 3406490 3401863
drugs; emergency room visits, 3404894; myocardial ischemia, 3400851 Ambulatory care
pharmacists interventions, 3401528; prescribing pulmonary embolism; overview, 3406713 anticoagulants; clinics, 3405488
errors, 3405597, 3405788 Alternaria alternata; helmidiol; anthelmintic antineoplastic agents; handling, 3405878
ebastine; overview, 3401618 effects, 3405285 cerebrovascular disorders; pharmaceutical care,
gadopentetate dimeglumine; adverse reactions, Alternative medicine 92
3406474 aromatherapy; African perfumes, 3406887; clerkships; administration, 3402805
globulin immune; dermatitis, 3403533 bibliographies, 3407078; efficacy research, clinical pharmacists; allergy histories, 3401528;
heparin sodium; adverse reactions, 3402985 3406310; pharmaceutical care, 3407057 interventions, 3404806, 55, 3405511;
iohexol; adverse reactions, 3406474 Australia, 3401404 medicine clinics, 3405441; smoking cessation,
lamotrigine; dispensed for lamivudine, 3406477 bibliographies, 3407078 3405510
latex, 3406482; health professions, 3406483 hay fever; formulations, 3405789 clozapine; schizophrenia, 3404380
medical devices; complement activation, 3400004 HIV infections; patient care, 3406954 drug utilization; quality assurance, 3401989
opiates, 3401588 homeopathy; community pharmacy, 3406398; epilepsy; nurses, 3406344
overview, 3401793 pharmaceutical education, 3402801; pharmacists a 3405459; integrated health care,
pefloxacin; overview, 3402926 role, 3405607
petrolatum white; comparisons, 3400181 industry, pharmaceutical; science, 3401403 Pre Sane firms, 3405476; pharmac'
quinolones; overview, 3402926 information; Internet, 39 services, prescribing trends, 3406524
nifampin; prophylaxis, 3406525 medicinal plants; folk medicine, 3405604; Helicobacter infections; clinic, 3404078
rosin; contact dermatitis, 3400092 menopause, 3404494; pharmacists role, 3405589 HIV infections; costs, 3406954
sulfamethoxazole, combination, trimethoprim; overview; U.S., 3404751 hospital pharmacy; survey, —
desensitization, 3402319 patient information; drug histories, 3400740; hospitals; economics,
Tanacetum parthenium, 3401942 ists, 3405611 hypertension; pharmacists ie 3406454
tests; skin, 3403691 pharmaceutical care; pharmacists role, 3407057 injections; physician directed clinics, 3401540
thymic extracts; prophylaxis, 3405163 pharmacy, community; sales, 3404031 neoplasms; pharmacists protocols, 3404865
zidovudine; adverse reactions, 3401584 research; NIH, 3405568, 3406418 outpatients; pharmacoeconomics, 3404778
Allitridum; mechanism of action; macrophage- shark cartilage; neoplasms, 3401335 patient education; ASHP guidelines, 3403499
mediated cytotoxicity, 3400156 Althaea species; syrups; stability, 3403738 pediatrics; rational therapy, 3404973
Allium cepa Altitude sickness; medicinal plants; therapy, pharmaceutical care; cost benefit analysis,
extraction; chemical constituents, 3403308 3405970 3406955; managed care systems, 3405449;
S-methylcysteine sulfoxide; antidiabetic, 3401969 Altretamine; ovarian neoplasms; comparisons, telemedicine, 3405534
Allium porrum; nutrition, 3404693 3405617 pharmacists; warfarin clinics, 3404208
Allium sativum; S-allylcysteine sulfoxide; Aluminium oxide, see Aluminum oxide = hospital; warfarin monitoring,
antidiabetic, 3401969 Aluminum 575,
Allium tuberosum; constituents, 3400536 contamination; TPN, 3400031 pharmacists, institutional; prisons, 3405393
Allocryptopine; aldose reductase inhibitors; in decomposition preducts; sucralfate suspensions, 'y; pharmaceutical care, 3404142
vitro, 3402654 pharmacy services; nt of Veterans
Alclileno3otin4pescr0uhoam1rmcai6itnn7itioo3aanl nss ti; s ; tahzcearutathpaiyon,pe roiu3ns4e,0, 5833844300 50668456 ; food Alcanoustmemablciieicnndtausit;om in o,rn eh,v3y i4de0mrw0a,o5 gx7in36de4;es0 i1nu2em4u 0tr haylidzraotxiiodne,; 3f4l0a1vo7r2 0 pAhifehmfaapalrritmorhs av,ec cmoa3rete4nh,0te 5,r38 a45p037y54; 40 51cGl05ie;7nr 9im;clsa ,an yryoe3,fui4 tl0 l5 3c44ch9l0ai13nn;5gi 2ces6sq,;, u a3li4in0 t1e5g3r0at;5e ;d
altlo-xticriatnys;- Retipnusotiucl odaecrimad,, s3e4e0 4T9r2e7t inoin co3m4b0i0n9at3i0o n, magnesium oxide; coatings, U3.4S0.5 5A3r6m y, 3405859; warfarin protocols,
S-Allylcysteine sulfoxide; Allium sativum; interactions; ciprofloxacin, 3405977 primary care; pharmacotherapists, 3405522,
antidiabetic, 3401969 Aluminum hydroxycarbonate; filtration; cakes, 3405533
Alna, see Tamsulosin hydrochloride 3406435 smoking; cessation clinics, 3405481
Alnus hirsuta; pedunculagin; antineoplastic effects, Aluminum oxide; combination, magnesium Amebicides
3405168 hydroxide; comparisons, 3404487 diloxanide furoate, combination, metronidazole;
Aloe barbadensis Aluminum stearate; suspending agents; insulin spectrometry, 3406
8-[[(CR-)B--2D--h[y2d-rOo-x(yEp)r-ocpiynln]a-m7o-ymle]tghloyxcyo-p5y-rmaentohsyyll-} -2- Almiucmriosnpuhme ressu,l fa3t4e0;3 7s3p5h eres; release, 3400283 Ampearnoomrormhyecai n; cutaneous leishmaniasis, 3405938
chromone; anti-inflammatory effects, 3405280 Aluminum tristearate, see Aluminum stearate contraceptives; lactation, 3404309
jojoba oil; claims substantiation, 3403377 Alverine citrate; colonic diseases; functional, overview, 3406680
loe vera 3406776 American Academy of Pediatrics
Aloe barbadensis; claims substantiation, 3403377 Aizheimer’s disease guidelines; drug excipients, 3405659
constituents, 3402658 arecoline hydrobromide; pharmacokinetics, immunization; dosage schedules, 3405944
natural products; quality control, 3402865 3403859 protocols; invasive pneumococcal infections,
Aloin; metabolism; nutrition, 3403890 BMY-21502, 3404931 3405690; ssis vaccines, 3405680; polio
Al caregivers; issues, 3407003 vaccines, 3405687
minoxidil, 3401118 central nervous system drugs, 3404353 varicella vaccines; protocols, 3406353
therapy; overview, 3401100 diagnosis, 3401791 American Association of Colleges of Pharmacy
Alopecia areata; overview; therapy, 3406083 E-2020; overview, 3406082 administration; science, 3407032
Aloysia triphylla; perfumes, 3406887 epidemiology; overview, 3406685 certification; CE, 3404797
Alpha hydroxy acids eptastigmine, 340084 Commission to Implement Change in
availability, 3403692 estrogens; postmenopause, 3402312 Pharmaceutical Education; economic, sociologic
glycolic acid; formulations, 3400289; skin galantamine; review, 3400148 impacts, 3407031
properties, 3405153 Internet; resources, 3402171 directories; PharmD programs, 3400695
lactic acid; skin properties, 3405153 new drugs; development, 3406626 educators; activities, 3402803
D-lactic acid; skin properties, 3405153 nimodipine, 3400883 grants; pharmacy practice research, 3405436
L-lactic acid; skin properties, 3405153 pharmacists consultant; role, 3407060 membership; administration, 3404077
skin; review, 3404471 review, 3401149; pathogenesis, 3406794; recent American Association of Pharmaceutical
skin aging; OTCs, 3406724 advances, 3406655 Scientists; employment; survey, 3403387
Alpha-hydroxy acids; advertising; industry claims, selegiline; review, 3401767 American College of Chest Physicians
3401400 tacrine; postmarketing surveillance, 3406533 protocols; anticoagulants, 3401658; oral
Alpinia japonica; sesquiterpenes, 3403902 tacrine hydrochloride, 3401066; pharmacist anticoagulants, 3402317
Alpinia speciosa; sesquiterpenes, 3403902 monitoring, American College of Clinical Pharmacy
Alprazolam therapy; overview, 3401181; review, 3406801 critical pathways; pharmacists role, 3400733
interactions; erythromycin, 3403628; kava, zolpidem tartrate; insomnia therapy, 3406527
Pretec nefazodone, 3406644 Am-80, see Tamibarotene
Al Amantadine
impotence, 3403158; overview, 3401821, influenza, 3401639; protocols, 3404206 Council on
3404392; urethral, 3402963 interactions; review, 3400222 certification; CE, 3404797
1090 International Pharmaceutical Abstracts
Subject Index 4-Aminothialenes
standards; pharmaceutical education, 3402819 manufacturing; protein engineering, 3400766 (R)-(+)-Aminoglutethimide; chromatography,
American Druggist salts; solubility, 3402400 liquid; aqueous solutions, 3403243
history; 1936, 3402029 Amino acid antagonists; L-701324; LC, 3401892 Aminoglycosides
journals; history, 3400747 Amino acid derivatives; synthesis; anticonvulsant amikacin; M. avium complex, 3400973;
merican Institute of the History of Pharmacy; activity, 3400419 comparisons, 3404204; dosage schedules,
role; volunteer project, 3402027 Amino acids 3404701; prescribing, 3400690
American Journal of Health-System Pharmacy aggregation; proteins, 3400940 amikacin sulfate; incompatibilities, 3403724;
administration; article topics, 3401473 ae p-coumaroylamino acid accumulation, stability,
policies and procedures; industry ties, 3404103 66' arthritis; infectious, 3403258
American Medical Association; attitudes; direct- alanylglutamine; TPN, 3401257 dosage schedules; costs, 3400687; optimization,
to-consumer advertising, 3406370 Allium species; antidiabetic, 3401969 3403202; rational therapy, 3403209; review,
American Pharmaceutical Association ‘y-aminobutyric acid; V. officinalis, 3404676 3401108, 3404304
attitudes; direct-to-consumer advertising, 3406370; arginine aspartate; metabolism, 3403294 drug utilization; review, 3404986
drug recall process, 3406937 aspartic acid; fleroxacin injections, 3400352 gentamicin; combined therapy, 3404968; dosage
immunization; pharmacists role, 3400806 carnitine; LC, 3404606 errors, 3401401; nanoparticles, 3405080;
Internet; user’s guide, 3405817 N-chloro-amino acids; dechlorination reactions, neonates, 3401905, 3405583; pharmacokinetic
pharmaceutical care; future growth, 3404807 3403214 models, 3400589; pharmacokinetics, 3405313;
American Pharmacy Alliance; industry; chromatography, liquid, 3400460 Pseudomonas infections, 3401592; release,
computers, 3402857 creatine monohydrate; inborn errors of 3402582; tissue levels, 3404614; toxicity,
American Society for Parenteral and Enteral metabolism, 3405917 3404680, 3406496
Nutrition cysteine; FK-409 stability, 3406604 gentamicin crobefat; bacterial endocarditis,
protocols; nutritional support, 3406303 Eichornia crassipes; content, 3401340 3405043
standards; nurses, 3403620 emulsions; stability, 3406589 gentamicin palmitate; bacterial endocarditis,
American Society of Consultant Pharmacists enantiomers; analysis, 3405217
certification; geriatrics, 3407014; pharmacists glutamine; enteral nutrition, 3405262; TPN, gentamicin sulfate; costs, 3400643;
consultant, 3401996 3401257 incompatibilities, 3403724; MIC, 3406260;
guidelines; controlled substances disposal, glycine; absorption, 3406234 microspheres, 3406566; SC levels, 3403254;
3406462 glycine, combination, aspirin; pharmacokinetics, stability, 3400964
legislation; health care, 3401999 3405017 incompatibilities; latex pump reservoirs, 3400965
lobbying; congress, 3404825 hydrophobicity; models, 3406906 isepamicin; pharmacokinetics, 3400484
prescribing; pharmacists, 3402001 incompatibilities; ceftriaxone, 3405113; neomycin sulfate; interactions, 3406213
American Society of Health-System Pharmacists cimetidine, 3406068; Shosaikoto, 3403092 pharmacokinetics; equations, 3400574; pharmacy
attitudes; assisted suicides, 3401399; direct-to- iontophoresis; electroosmotic flow, 3404220 services, 3400801
consumer advertising, 3406370; drug recall methionine; diet, 3402455; growth, 3401117 rational therapy; pediatrics, 3404974
process, 3406937 nutrition; organ specific, 3404512; whey resistance; Enterococci species, 3404641
cfloirnmiuclaal ripehsa; rmsatcayn;da rdskiizlaltsi odne,v e3lo4p0m1e5n4t4, 3405525 Pafnoarxm ulgaisn,s en3g4;0 59is3o9l ation, 3404659 re3s4pi0r2a4t6o9ry tract infections; HIV infections,
grants; pharmacy practice research, 3405436 parenteral nutrition; acute kidney failure, streptomycin; dissociation constants, 3402424
guidelines; clinical care plans, 3403500; errors, 3401231; precipitation, 3400126; stability, tobramycin; pharmacokinetics, 3405313;
3403399; investigational drug services, 3405442; 3400345 prescribing, 3404419
patient consultation, 34034! 99 phenylalanine; absorption, 3406234 tobramycin sulfate; incompatibilities, 3403724;
meetings; programming, 3400059 D-phenylalanine; absorption, 3406234 stability,
membership; Louisiana pharmacists, 3400052 Pistia stratiotes; content, 3401340 toxicity; meta-analysis, 3405334
pprhoatromcaolcsy; sAeCrvEi ceisn;h ibsiutrovresy,, 33440034588642;, S3.4 05874 pprrooldiuncet; dteravneslpooprtm,e nt3;4 03C9h5i2n a, 3402118 9-qAumiinnoloi-n2e, 3,m5o,n6o,h7y,d8r-ohcehxlahoyrdirdoe- 1Hm-ocnyochlyodpreanttea,[ b]s-ee
pneumoniae resistance, 3404863; tuberculosis, reactions; propanedial, 3400435 Amiridin
AmNeutrri0ic3ta5ino8 n5; Sopcrioettoyc olosf; Paalrgeonrtietrhamls , an3d4 04E9n8t7e ral Amsttaiaunbroiilnaielt;yk ;y bllT oPoNcd,y c ll3eav4ne0ol0ns,e3 s4;93 40s5y2nt0h8e sis; antipsychotic Amppiseonrromileaaestivsiu;ol ni;pn riocst torpaaoctriupdm hycroirnn euImX , ac3c4u0m3u6la4t5i on,
Amper3or4ti0oc3co6al1ns3 ;, Tch3oo4mr0ma3uc6ni1ic6t yS-oacciqeutiy red pneumonia, Amasigoelnnuotbasi,ll ikzy3il4n g0 1m2ae8gte0hn tasc;r ytlaasttee, 3c4o0p3o4l8y9m er E; 53--AA3mm4ii0nn3oo6l-0e25v- umleitnhicy l-a1c-idp,h esneye lpArmoipnoalneovnuelsi;n ic acid
Ampehrarimcaacnys; waidtmhi niDsitsraabtiiloint,i es3 4A0c4t7;1 5p ersonnel, 7-[(1R,5S,6s)-6-A mino-3-azabicyclo[3.1.0}hex-3- synthesis; antilipemic activity, 3402520
Amersham International; product development; yl]-1-(2,4-difluoropheny!)-6-fluoro-4- oxo-1,4- 3-Amino-1-(2,3,4-mononitro)propan-1-ones;
technology transfer, 3402764 dihydro-1,8-naphthyridine-3-carboxylic acid synthesis; antilipemic activity, 3402515
Amethocaine, see Tetracaine mmeosnyolmaetteh anesulfonate, see Trovafloxacin 3-aAnmtiilniop-e1mi-c( 2,ac3t,i4vi-tmy,o no34)0p2r5o1p5a n-1-ones; synthesis,
Ametop, see Tetracaine
Amgen; biotechnology; history, 3402761 (la,5a,6a)-7-(6-Amino-3-azabicyclo[3.1.0}hex-3- Aminonitrothiazole; metabolites; nitazoxanide,
Amides yl)-1-(2,4-difluorophenyl)-6-fluoro- 4-oxo-1,4- 3406219
N-benzyloxycarbonylglycine derivatives; dihydro-1,8-naphthyridine-3-carboxylic acid Aminophylline
convulsions, 3404478 monomethanesulfonate, see Trovafloxacin errors, medication; nomenclature, 3404032
Euscaphis japonica; isolation, 3401951 mesylate granules; sustained-action, 3405079
glycine derivatives; convulsions, 3404478 2-Aminobenzimidazoles; synthesis, 3401874 incompatibilities; TrophAmine, 3400330
Telesto riisei; cytotoxicity, 3402642 Aminobenzoic acid interactions; deoxyvasicine derivatives, 3403816;
Amifostine chromatography, liquid; photodecomposition, midazolam, 3405765; pantoprazole, 3403629;
cytoprotectants; selection, 3405538 3404560 phenobarbital, 3401677
overview, 3400978, 3401128, 3401160, 3403161, emulsions; micro-, 3403741 pharmacokinetics; theophylline excretion,
3404300 transport; permeation models, 3402214 3404627
review, 3406073 4-Aminobenzoic acid, see Aminobenzoic acid release; resin beads, 3402368
Amikacin p-Aminobenzoic acid, see Aminobenzoic acid Aminoplex 12; incompatibilities; cimetidine,
dosage schedules; antibacterial effects, 3404701; S antendtetenneteton chromatography, 3406068
fecvoesrt;s , co3m4p0a0r6i8s7o ns, 3404204 3-lAiqmuiindo; -1t,i2r,a4pa-zbaemniznoet rimaetzaibnoel-i1te-so,x id3e4;0 5224 S-a2ci-d(,3 -sAeem iAnmoipfroosptyilnaem i ye7 e
Mycobacterium avium complex, 3400973 chromatography, liquid; tirapazamine metabolites, 4-Aminopyridines; multiple sclerosis; overview,
prescribing; costs, 90 5224 3406669
Amikacin sulfate 8-Amino-1,3-bis(cyclopropylmethyl)xanthine, see Aminopyrine; permeation; rat skin, 3405988
incompatibilities; filgrastim, 3403724; Cipamfylline Aminoquinolines; complexes; bromophenol blue,
polypropylene, y-Aminobutyric acid; Valeriana officinalis; 3403082
Amikin, see Amikacin sulfate synaptosomes, 3404676 Aminosalicylic acid
Amiloride Aminocaproic acid; toxicity; rhabdomyolysis, binding; mucus glycoproteins, 3406238
chromatography, liquid; tablets, 3403848 3405670 permeation; cystic fibrosis mucus, 3404366
combination, furosemide; misuse, 3400821 e-Aminocaproyl derivatives; fibrinolysis, 3406689 5-Aminosalicylic acid, see Mesalamine
Amiloride hydrochloride; incompatibilities; 4-Amino-6-chloro-1,3-benzenedisulfonamide; Le sme acid, see Aminosalicylic acid
furosemide, 3406067 chromatography, liquid; hydrochlorothiazide a-Ami imides; synthesis; pres n otal
Amine fluorides; structure-activity relationships; tablets, 3404601 3405178
antibacterial effects, 3404452 (—)-(S)-10-(1-Aminocyclopropyl)-9-fluoro-3- 4-Aminothialenes; synthesis, 3403798
Amine oxides; Escherichia coli; SOS chromotest, methyl-7-oxo-2,3-dihydro-7H- — (6R,7R)-7- [(Z)-2-(2-Amino-4-thiazol)-2-hydroxy-
3406692 [1,4]benzo: - amnaes ink acid, see ido}-8-oxo-3- (1,2,3-triazol-5-
Amines Pazufloxacin yl)thiomethyithio-5-thia-1- -azabicyclo[4.2.0]oct-
chromatography, liquid; computer optimization, 3-Amino-1-(2,3,4-dihalopheny!)propan-1-ones; 2-ene-2-carboxylic acid, see S-1090
3403453 synthesis; antilipemic activity, 3402515 = -(6R,7R)-7-(2-(2-Aminothiaza-4)-2()-
incompatibilities; ceftriaxone, 3405113; Aminoglutethimide; breast neoplasms; t 3- (1H-1,2,3-triazol-
dihydroxyacetone, 3403728 reimbursement, 3404054 4-ylsulfanyimethyisulfanyl)-3-cephem-4-
International Pharmaceutical Abstracts
4-Aminothialenes Subject Index
carboxylic acid monohydrochloride toxicity; overview, 3402921 acetaminophen, combination, aspirin; analysis,
monohydrate, see S-1090 Amphiphiles; 3(S)-((2-carboxyethy!)sulfanyl]-3-[2- 406866
Amiodarone (8-L vs ay > waa acid disodium; acetaminophen, combination, aspirin, caffeine;
atrial fibrillation; overview, 3405152 ionic strength, 3403363 spectrometry, 3401889
death; sudden cardiac, 3405354 Amphotec, see Amphotericin B acetaminophen, combination, azatadine maleate,
interactions; — agents, 3400222; Amphotericin B pseudoephedrine hydrochloride; TLC, 3406857
warfarin, 3400985 adverse reactions; anaphylaxis, 3400091 acetaminophen, combination, caffeine, dipyrone;
toxicity; neutropenia, 3404167; pulmonary aspergillosis; aerosols, 3401750 absorbance ratio analysis, 3406851
fibrosis, 3400143; thyroid diseases, 3404896 complexes; cholesteryl sulfate, 3406327 acetaminophen, combination, chlorzoxazone,
Amiodarone hydrochloride compounding; fat emulsions, diclofenac sodium; chromatography, 3406167
arrhythmia; overview, 3403124 encapsulation; liposomes, 3401274 acetaminophen, combination, codeine; pain,
formularies, 3401569 fat emulsions; ophthalmic preparations, 3404222; 3400186
heart failure; overview, 3406691 pharmacokinetics, 3404226 acetaminophen, combination, diclofenac sodium;
review, 3401008 FDA; new indications, 3403159 simultaneous spectrometry, 3406859
Amiridin; metabolites; synthesis, 3401278 formulations; comparisons, 3401323; lipids, acetaminophen, combination, mefenamic acid;
Amisulpride; schizophrenia; review, 3403551 nutrition, 3406639 simultaneous spectrometry, 3406169
Amithiozone; solubility; isoniazid, 3406050 immunoassay; blood levels, 3405756 acetaminophen, combination, sulfapyridine; LC,
Amitriptyline incompatibilities; fat emulsions, 3400334; 3406847
complexes; transdermal flux, 3402371 granisetron, 3402432; lipid emulsions, 3405099; administration routes; injections, 3401850
errors, medication; nomenclature, 3404032 soybean oil, 3405098; stability, 3405560 aethiopinone; S. aethiopis, 3403340
interactions; sertraline, 3405005 injections; diluents, 3401021; home health care, aminopyrine; rat skin permeation, 3405988
peripheral nervous system diseases; HIV 3402134 aminosalicylic acid; mucus binding, 3406238
infections, 3404376 liposomes; overview, 3404221 Angelica sinensis, 3401947
toxicity; angle-closure glaucoma, 3400825; meningitis; combined therapy, 3405704 antipyrine; cystic fibrosis, 3403872; excretion,
geriatrics, 3403553 overview; lipid complexes, 3401160 3406317; interactions, 3403283
utilization; UK, 3400849 spectrometry; blood, urine levels, 3400448 aspirin; breast neoplasms, 3404983; compaction,
Amitriptyline hydrochloride; interactions; stability, 3405564 3402224; diabetes mellitus, 3400836;
divalproex, 3400889 toxicity; kidney failure, 3400106, 3406496 disintegration, 3405825; interactions, 3401671,
Amlodipine utilization; evaluation, 3400163, 3400209 3401683; kidney failure, 3403607; migraine,
angina pectoris; comparisons, 3403610 Ampicillin 3400853; nutrition, 3401864; pain, 3401074;
heart failure; chronic, 3400169 chromatography, liquid, 3404587; method pregnancy, 3401259; release, 3402344;
hypertension; comparisons, 3405918; therapy comparisons, 3404573; milk residues, 3405202 spectrometry, 3403245; tablets, 3400971;
withdrawal, 3400988 combination, sulbactam; review, 3401764 toxicity, 3405924
patches transdermal; formulations, 3402384 concomitant therapy, 3400126 aspirin, combination, glycine; pharmacokinetics,
Ammonia detoxicants incompatibilities; TrophAmine, 3400330 3405017
sodium benzoate; comparisons, 3403604 injections; contamination, 3400113 aspirin, combination, phenobarbital; UV
sodium phenylacetate; comparisons, 3403604 pneumonia; combined therapy, 3406495 spectrometry, 3404525
sodium phenylbutyrate; comparisons, 3403604 utilization; evaluation, 3401622 Bauhinia splendens; constituents, 3403333
Am34m0o6n15i9u m chloride; kinetics; water sorption, Ammpeitchioldl inc omdpearriivsatoinvse,s ; 34c0h4r5o7m3a tography, liquid; bbuutporrepnhoarnpohli;n e;l ivecro mcpiarrrihsosoinss,, 3430430645911 8
Ammonium glycyrrhizinate, see Ampicillin sodium butorphanol tartrate; LC/MS, 3405215
Mi um glycyrrhizinate antibiotics; comparisons, 3405305
Ammonium peroxydisulfate; stability; viny! combination, sulbactam sodium; urinary tract ca3n4n0a1b2in8o3i ds; structure-activity relationships,
acetate polymerization, 3406573 infections, 3406715 cannabis; overview, 3403567
Ammonium persulfate, see Ammonium Ampuls
peroxydisulfate glass; gas permeation, 3401521 ca3p4sa0i1c6i9n0; arthritis, 3403132; skin absorption,
Ammonium salts; Escherichia coli; SOS manufacturing; automation, 3401523 clonidine; comparisons, 3404918; pain, 3403770
chromotest, 3406692 Amsacrine; incompatibilities; granisetron, 3402432 common cold, 3403181; overview, 3401095
AAAmmkmsnitnmaniebeoositltiniiciaitscy;;u; mfwkz laeoutrliseapdurt il idflnaseeotovmcree yp lttstei a orntgr,a rtoe3w;4 t0ht6 o1xfi5ac9ci ttoyr,, 33440005112182 AAAmmmh3yysy4llud0oolr2idoo3desc0oxih9stnl iro sri;hin yd;de mr eoclcophmhlpaoalrcaitndi;eo ,nc ;o nsegseeu rsftTaiacvmees ualhreoeaasr,it n3 f4a0il0u9r3e,1 cccdoooesmnxtpcksa;oe rmtiiomstpeoarcnnohstfa; en nit chnaeatlrpr aropomyvxe,ee tnnth3,ia 4lma0it33ni45oe03n;2,7 4 5o33v4 e0r5v6i0ew9, 3404938
pzihdeonvouxdyibnee;n zarmatisn, e;3 40p5l2a4c2e ntal transfer, 3405231 Amcyomlboisnea tion, ethylcellulose; release, 3400246 ddeizaocceitnyel;m oropphiiantee ; dedpoesnadgeen,c e3,4 0304802039 86
Amodiaquine; pharmacokinetics, 3403278 matrices; image analysis, 3402367 3-{4[4,5-dihydro-5-(substituted aryl)-1H-pyrazol-
Amonafide; review, 3400844 Amyotrophic lateral sclerosis; riluzole; overview, 3-yl]phenyl}sydnones; synthesis, 3401292
Amoora rohituka; neoplasms, 3405298 3404331 dipyrone; comparisons, 3400354; diabetes
Amoxapine; interactions; antiparkinson agents, a-Amyrin; Papaver rhoeas; isolation, 3401341 mellitus, 3406870; LC, 3406853; neuroleptic
Amcc3ooo4pwxmm0ihibb0taciih2irnn 2lmaa2elattf iiicfnooou nnse,,ico onn,cc ollaam3vvi4uucl0lsaa4,nn1i a9ct4 e3 4a0cp6iod3t;8a 0sd soigu m;b itoetsi,t is3 40m6e0di7a8 ; ABn-aaatbAe3hbumdl4souye0eltcr0,iea i6sct;6n i3 2;o4;an a0 agb5leuP3t sna4oetpx5,vsia; ic v die3etray4ot, t0h a6lrp3e9het4o7see09,sa0, s 1;31 34540i 0s50o4l63a51t3i;,o n ,O 3l43y04m10p41i03c5s4;,1 fffeeeptmvnnaraettiarlaan;ninn, sygy ldlnp;3e ae r4dncmi0timaa0 tetlr2dra s1iity7cecpn;s;aa ,d tt riciponoh3amjen4tese 0cc,,3th e 7iero63sr3no34 s4r,0,s0t 3,r5 5a9338n03449s4700d 0 33e15r74m865a942l ,; 3n4e0o2p3l8a1s;m
concomitant therapy, 3402928, 3405714 steroids; _— distribution, 3402600; education, furosins; P. sellowianus, 3406288
Helicobacter infections; combined therapy, gastrointestinal hemorrhage, 3404919
3406728; comparisons, 3401653; therapy failure, Anagyris foetida geraniin; P. sellowianus, 3406288
3402304 5,6-didehydrolupanine; isolation, 3403352 headache, 3401005, 3406809; overview, 3401253
otitis media; combined therapy, 3405962 rhombifoline; isolation, 3403352 herpes zoster, 3405963
sinusitis; comparisons, 3400189 Anakinra homovanillic amide derivatives; synthesis,
site of action; crosslinked polymer hydrogels, arthritis; rheumatoid, 3405912 35
3400942 incompatibilities; antimicrobials, 3403097 ibuprofen; abortion pain, 3402988; arginine
toxicity, 3400109 Analeptics, see Central nervous system formulations, 3403187; comparisons, 3402989,
utilization; evaluation, 3401622 stimulants 3402990, 3402991, 3402993; pain, 3401074
Amoxicillin sodium; incompatibilities; diluents, Analgesics and antipyretics ibuprofen, combination, pseudoephedrine;
3403743 acetaminophen; absorption, 3404225; blood common cold, 3406716
Amoxicillin trihydrate levels, 3406220; coated tablets, 3406583; interactions; anticoagulants, 3400221
combination, clavulanate potassium; comparisons, compaction, 3402224; contamination, 3401598; ketoprofen; pain, 3401074
3402057; urinary tract infections, 3406715 dissolution, 3405058; dissolution rates, 3404260; ketorolac; comparisons, 3402990, 3402991
toxicity, 3403534 enset vs potato starch, 3400921; extrusions, ketorolac tromethamine; dissolution rates,
Amoxil, see Amoxicillin trihydrate 3400037; floor stock, 3405487; interactions, 3406560
Amoxycillin, see Amoxicillin 3401672, 3403623; kidney failure, 3403607; low lactation, 3403858
Ampakines; Alzheimer’s disease; therapy, 3406626 back pain, 3404291; nitric oxide toxicity, linarin; B. cordata, 3404667
Amphetamine; interactions; scopolamine, 3400238 3404709; nomenclature, 3401478; nomograms, Lumbricus spencer; fever, 3405924
Amphetamine te; combination, 3405228; osteoarthritis, 3404318; overdose, medicinal plants; history, 3405782
amphetamine sulfate, dextroamphetamine 3404901; pain, 3401074; pain measurement, melandrin, 3403200
saccharate, dextroamphetamine sulfate, 3406718 3406323; pediatrics, 3400180; permeation, methyl salicylate; skin absorption, 3400241
Amphetamine sulfate; combination, amphetamine 3402370; polymorphonuclear leukocytes, mirfentanil hydrochloride; liposomes, 3400918
aspartate, dextroamphetamine saccharate, 3406752; release, 3400908, 3405724; solubility, morphine; dosage, 3400823; neoplasm pain,
dextroamphetamine sulfate, 3406718 3403041; spheres, 3400283; spheroid production, 3400217
Am| 3403467; stability, 3403701; sustained-action, morphine sulfate; errors, 3400895
abuse; adolescents, 3405353; MDMA tablets, 3402348; tablets, 3400035; toxicity, 3404997, naproxen; pain, 3401074
3401385; tests, 3406182 3405899; xylitol tablets, 3405845 naproxen sodium; comparisons, 3402993
1092 International Pharmaceutical Abstracts